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Overview  
This thesis focuses on the assessment of autism spectrum disorder (ASD) in 
individuals who have reached adulthood without ever having received a diagnosis 
and, in particular, on distinguishing features of ASD from those of other mental 
health difficulties in a potentially complex adult clinical population.   
Part 1:  This section systematically reviews literature estimating levels of co-
occurrence of ASD and psychotic disorders.  Fourteen studies investigating the 
prevalence of psychosis in adults diagnosed with ASD and six studies estimating the 
prevalence of ASD in adults diagnosed with a psychotic disorder were included.  The 
review concludes that lifetime prevalence of psychosis in adults with ASD may be 
higher than in the general population and explores factors which might explain an 
association between these disorders.   
Part 2:  This section is an empirical paper reporting a study designed to validate the 
Developmental, Diagnostic and Dimensional Interview - Short Form Adult Version 
(3Di-sva) in a clinical population.  The 3Di-sva is a new informant-report interview 
for the diagnosis of ASD in adults.  The interview was conducted in respect of 27 
individuals diagnosed with ASD and 20 clinical comparison participants diagnosed 
with a range of mental health difficulties.  The 3Di-sva was found to display good 
psychometric properties including interrater reliability, internal consistency, criterion 
validity and sensitivity and specificity.  This research was conducted in collaboration 
with another UCL Clinical Psychology Doctorate student (Clarke, 2015) who 
evaluated the psychometric properties of the 3Di-sva when used in a non-clinical 
comparison population.   
Part 3:  This section provides a critical appraisal of the systematic literature review 
and major research project, reflecting on aspects of clinical experience which 
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contributed to the work undertaken, ways in which the process of carrying out the 
study influenced my perspective on research and clinical practice, and 
methodological challenges that were encountered. 
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Abstract 
Background.  Autism spectrum disorder (ASD) and psychotic disorders share a 
complex, related history underpinned by a longstanding interest in the possibility of 
an association between them, recognising commonalities in areas of behavioural 
phenotype, susceptibility genes and sociocognitive functioning.  Nevertheless, the 
relationship between ASD and psychosis remains unclear and evidence as to whether 
each of: (i) prevalence of psychosis in adults with ASD, and (ii) prevalence of ASD 
in adults with psychosis, may be higher than in the general population is equivocal. 
Aim.  To review current literature investigating the prevalence of psychosis among 
adults diagnosed with ASD and the prevalence of ASD among adults diagnosed with 
a psychotic disorder.  
Method.  Systematic literature searches were performed using Psychinfo and OVID 
MEDLINE and manual searches of reference lists.  These searches identified 20 
articles meeting quality and relevance criteria for review.  
Results.  There is conflicting evidence regarding the co-occurrence of ASD and 
psychosis, with prevalence estimates varying widely and studies investigating the 
issue tending to be associated with a certain risk of bias.  Prevalence estimates of 
psychosis in adults with ASD, as reported in the included studies, ranged widely 
from 0% to 61.5%.  However, based on the results of this review, it is suggested that 
the lifetime prevalence of psychosis in adults with ASD may be higher than in the 
general population at around 12-13%.  Estimates of prevalence of ASD in adults with 
psychotic disorders ranged from 0.8% to 27% in the studies reviewed.  These studies 
were too few in number, associated with too great a risk of bias and too heterogenous 
for a meaningful conclusion to be reached as to the likely prevalence of ASD in a 
psychosis population.  
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Conclusions.  Clinicians working in adult ASD and psychosis services need to be 
mindful of the possibility of co-occurrence when assessing individuals.  Additional, 
well-designed, population based studies are needed to determine the true level of co-
occurrence of these disorders.   
15 
 
Introduction 
Autism spectrum disorder (ASD) is a lifelong developmental condition 
characterised by two groups of symptoms: (i) social communication and interaction 
difficulties, and (ii) restricted, repetitive behaviours and unusual sensory perception 
(Diagnostic and Statistical Manual of Mental Disorders, 5
th
 ed.; DSM-5; American 
Psychiatric Association [APA], 2013a).  There is evidence that many individuals 
with ASD will experience other mental health difficulties during their lives, (Geurts 
& Jansen, 2011; Mukaddes, Hergüner, & Tanidir, 2010). Given the impact that such 
comorbidity may have on the long term outcome, quality of life and functioning of 
these individuals, it is important that coexisting conditions are recognised (National 
Institute for Health and Clinical Excellence [NICE], 2011).   
One such group of potentially coexisting mental health conditions is the 
psychotic disorders, characterised by a significant alteration of an individual’s 
thoughts, mood, behaviour and perception (NICE, 2014).  DSM-5 (APA, 2013a) 
describes “schizophrenia spectrum and other psychotic disorders” as being 
characterised by dysfunction in one or more of five domains: delusions (beliefs that 
are rigidly held notwithstanding conflicting evidence), hallucinations (perceiving 
something in the absence of an external stimulus), disorganised thought (manifesting 
in disorganised speech), grossly disorganised or abnormal motor behaviour and 
negative symptoms (such as, diminished emotional expression and low motivation). 
Psychotic disorders are recognised as being heterogeneous, with considerable 
variation in the combination of symptoms experienced by individuals and in the 
course which these disorders may follow (NICE, 2014).  
Autism and psychosis share a complex, intertwined history.  In 1911 Eugen 
Bleuler used the term ‘autism’ to describe a key feature he observed in 
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schizophrenia, that is, a withdrawal by the individual from outer reality in favour of a 
retreat into the inner world (Parnas, 2011).   In 1943 Leo Kanner borrowed the term 
‘autistic’ from the schizophrenia literature to describe a group of children he 
observed in the clinic displaying ‘extreme aloneness’ and a strong, obsessive wish to 
preserve sameness (Kanner, 1943).  This was the first published account of autism as 
a distinct syndrome characterised by traits which are now typically associated with 
the modern conceptualisation of ASD.  Throughout the 1950s and 1960s, autism was 
widely regarded as a psychotic disorder (DSM-II; APA, 1968) and the term was 
often used interchangeably with ‘childhood schizophrenia’.  By the 1970s, Michael 
Rutter’s research was contributing to the reconceptualisation of autism as a 
neurodevelopmental disorder that was qualitatively distinct from psychosis (Rutter, 
1978).  Rutter (1978) set out a number of key criteria according to which the 
syndrome of autism might be identified: (i) onset prior to 30 months of age, (ii) 
impaired social development, (iii) delayed and unusual language development and 
(iv) ‘insistence on sameness’ or stereotyped behaviours and routines, and he 
established the validity of this syndrome as one distinct from other clinical disorders.  
Consequentially, in 1980 the Diagnostic and the Statistical Manual of Mental 
Disorders, Third Edition (DSM-III; APA) defined infantile autism as a pervasive 
developmental disorder distinct from schizophrenia. 
 Recently there has been a revived interest in the possibility of an association 
between ASD and psychosis, recognising overlap in areas of behavioural phenotype, 
susceptibility genes and sociocognitive functioning, whilst acknowledging important 
areas of distinction, such as developmental course and association with epilepsy 
(Owen, O’Donovan, Thapar & Craddock, 2011; Rutter, 2013).  The disorders share a 
number of clinical features and researchers continue to search for evidence of 
17 
 
aetiological commonality underlying such shared features (Stone & Iguchi, 2011).  
Investigations have been carried out on a number of levels: (i) clinical 
symptomatology, (ii) neurobiology, and (iii) genes (Stone & Iguchi, 2011).   
There is considerable overlap in symptomatology between the two disorders, 
for example, social withdrawal, flattening of affect, oddness, restricted interests and 
disordered thinking (Sasson, Pinkham, Carpenter & Belger, 2011).  In particular, 
social cognitive deficits, such as impaired ‘theory of mind’, are a key feature of both 
conditions (Craig, Hatton, Craig & Bentall, 2004).   
Research in both fields has sought to discover shared neurobiology which 
may underlie such clinical symptoms, however the evidence remains equivocal 
(Stone & Iguchi, 2011).  Cheung et al. (2010) reviewed literature relating to the brain 
anatomical phenotype of ASD and schizophrenia, as assessed by neuroimaging 
findings.  Whilst they found areas of considerable overlap between the two disorders 
in terms of brain volume as compared to controls (e.g. low volume of grey matter in 
limbic-striato-thalamic circuits), there were also areas of clear distinction, for 
example grey matter deficit in the left putamen in ASD and deficits in the amygdala 
for schizophrenia (Cheung et al., 2010).  
Twin studies suggest that both schizophrenia and ASD carry a significant 
genetic component in their aetiology (Stone & Iguchi, 2011).  There is also evidence 
that these disorders share common genetic susceptibility factors, for example, Copy 
Number Variations (CNVs; submicroscopic chromosomal deletions or duplications 
which can result in an increase or decrease in gene expression) at specific locations 
have been found to be associated with both ASD and schizophrenia (Burbach & van 
der Zwaag, 2009; Cook & Scherer, 2008; International Schizophrenia Consortium, 
2008).  Studies report finding recurrent CNVs in the same chromosomal regions and 
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single genes in both individuals with autism and in those with schizophrenia (e.g. the 
1q21.1, 15q11.2 and 15q13.3 regions, Burbach & van der Zwaag, 2009).  However, 
other studies estimate the overlap in such genetic processes to be modest, suggesting 
that, whilst reciprocal variants constitute risk factors for both conditions, they 
manifest differently in the two disorders (Crespi, Stead & Elliot, 2010).   
Research continues to investigate whether comorbidity reflects common 
underlying causality, whether each condition represents an alternate form of the same 
disorder, or whether these populations represent distinct groups that happen to share 
the same surface attributes.   
Recent studies suggest that adults, as well as children, with ASD have high 
rates of psychiatric comorbidity (Joshi et al., 2013).  However, research into the 
prevalence of psychosis in an adult ASD population has been somewhat neglected 
and the evidence that does exist appears to be equivocal (Davidson, Greenwood, 
Stansfield & Wright, 2013).  It is important for clinicians working with an ASD 
population to understand whether the difficulties associated with ASD convey a 
particular risk of developing psychosis and to consider the possibility of comorbid 
psychotic disorders rather than misattributing symptoms of psychosis to ASD.  Such 
misattribution may deprive the individual of the possibility of receiving specific 
treatment appropriate to psychosis and, in particular, access to early evidence-based 
intervention as recommended by NICE guidelines (2014).  Conversely, there is also 
the risk of clinicians mistaking the unusual, restricted interests associated with ASD 
for psychotic delusions (Dossetor, 2007), which could result in the administration of 
inappropriate medications with significant side effect profiles.  In addition, clinicians 
working in psychosis services report individuals attending the clinic who appear to 
present with features of ASD but have not been diagnosed with the disorder 
19 
 
(Davidson et al., 2013).   Diagnosis of ASD is important in enabling individuals to 
access vital targeted support from health and social services since many adults with 
ASD suffer exclusion both socially and economically (NICE, 2012).   
Aims of this review 
Gaining a clearer understanding of the likelihood of co-occurrence of ASD 
and psychosis is important in informing best clinical practice and in guiding future 
research into areas of commonality and difference and into effective treatments for 
individuals who experience comorbidity.  Thus, this review aimed to tackle 
limitations in the ASD and psychosis literature by examining: (1) research into the 
prevalence of psychosis in individuals diagnosed with ASD and (2) research into the 
prevalence of ASD in individuals diagnosed with a psychotic disorder, with a view to 
discovering whether, according to current evidence, such prevalence in each case 
may be higher than in the general population.  
Method 
Search strategy 
 A systematic search of the PsychINFO and Ovid MEDLINE computerised 
databases was undertaken from database inception to 15 September 2014 (see 
Appendix A for details).  The terms autis*, ASD, asperger*, pervasive 
developmental disorder or PDD were combined with psychosis, psychotic or 
schizophren* in a search of titles, abstracts and keywords of studies entered in these 
databases. In addition, medical subject headings were searched. The search results 
were limited to English language and human subjects. The reference lists of the 
included papers were also searched by hand.  
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Inclusion criteria 
This review included studies meeting the following criteria:  (1) the target 
population included adults (aged 18 or over); (2) the sample included individuals 
with an IQ (full-scale or estimated) of 70 or above; (3) the article reported on the 
prevalence of comorbid psychotic disorders in individuals diagnosed with an ASD, 
or on the prevalence of comorbid ASD in individuals diagnosed with a psychotic 
disorder; (4) the article reported an original piece of research; (5) the study was 
published in a peer-reviewed journal; (6) the study was published between January 
1994 and September 2014.   Studies meeting these criteria were formally assessed for 
quality and relevance.   
The review was limited to studies published after 1994.  This study period 
was selected because 1994 is the year that DSM-IV was published (APA) and that 
ICD-10 (World Health Organisation [WHO], 1992) came into use in World Health 
Organisation member states (WHO, 2015).  Diagnostic criteria for ASD have varied 
considerably over the years but by 1994 a degree of consensus had been achieved in 
conceptualising autism as a spectrum of developmental disorders.  DSM-IV and 
ICD-10 describe similar subgroups of disorder within the spectrum (Wing & Potter, 
2002) and cases diagnosed according to these principles show a high degree of 
correspondence to individuals diagnosed under current criteria (e.g., Huerta, Bishop, 
Duncan, Hus & Lord, 2012).  Studies published prior to 1994 would have relied on 
somewhat different diagnostic criteria thus limiting the generalizability of findings to 
current conceptualisations of ASD. 
For the purposes of this review Autism Spectrum Disorders includes any of 
the previously distinct ASD diagnoses described in DSM-IV (APA, 1994):  autistic 
disorder, Asperger’s disorder, childhood disintegrative disorder and pervasive 
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developmental disorder not otherwise specified (PDD-NOS). This is consistent with 
the approach to diagnostic criteria adopted by DSM-5 (APA, 2013a), which reflects 
research suggesting a single overarching disorder is a more accurate and useful way 
of conceptualising this spectrum of difficulties (APA, 2013b). 
The definition of “psychosis” in this review is fairly broad, encompassing the 
schizophrenia spectrum and other psychotic disorders set out in DSM-5 (APA, 
2013a), as well as unipolar or bipolar mood disorders where psychotic symptoms are 
expressly stated to coexist.  This definition reflects the broader end of the range of 
psychotic disorders reported in the literature (e.g. Davidson et al., 2013).   
Childhood-onset schizophrenia (COS), in which symptoms appear before 13 
years of age, is considered extremely rare, with a prevalence of approximately 1 in 
40,000, equating to around 0.025 cases per 1000 persons (Gochman, Miller & 
Rapoport, 2011), as opposed to an estimated lifetime prevalence of adolescent or 
adult onset schizophrenia (AOS) of approximately 4 per 1000 (e.g. Saha, Chant, 
Welham & McGrath, 2005).  COS is hypothesised to constitute a more severe form 
of the disorder, with studies suggesting COS is associated with greater brain 
morphologic abnormality, more severe neurobehavioural difficulties and greater 
genetic risk than AOS (e.g. Sowell, Toga & Asarnow, 2000).  In addition, the slight 
developmental delays observed in prospective cohort studies of AOS appear to be 
heightened in individuals with COS, with a substantial proportion of children with 
COS observed to manifest significant developmental abnormalities of 
communication and social relatedness consistent with a diagnosis of ASD (Rapoport, 
Chavez, Greenstein, Addington & Gogtay, 2009).  In view of these subtle 
distinctions between COS and AOS it was decided to exclude studies reporting on 
COS from this review.  This review focuses primarily on the co-occurrence ASD and 
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psychotic disorders in adults, although where studies included both adults and 
adolescents these were retained. 
In this review the term “learning disability” refers to individuals with an IQ 
below 70.  An IQ is stated to be in the “normal range” for individuals with an IQ of 
70 or more.  This review aimed to assess the occurrence of comorbid ASD and 
psychotic disorders in individuals across the range of intellect rather than specifically 
in adults with a learning disability.  As such, studies in which every participant met 
criteria for a learning disability were not included.   
Results 
 The PsychINFO and Ovid MEDLINE searches identified 3982 studies (after 
deduplication), of which 2729 were within the specified date range.  Abstracts of 
these studies were screened according to the inclusion criteria. Twenty studies met 
criteria (1) to (5) above and were subjected to formal quality assessment.  Reasons 
for exclusion included: genetic or physiological studies, review or conceptual papers, 
studies reporting on prevalence of ASD or psychotic traits rather than of cases 
meeting diagnostic criteria, case reports and studies in which the sample consisted 
entirely of children or individuals with a learning disability.  In the current project, 
the resources were not available for two researchers to apply inclusion criteria to 
papers identified in the search, and to then assess the level of consensus. 
Quality and relevance assessment 
 Quality of studies was assessed using a checklist developed by Hoy et al. 
(2012) for assessing risk of bias in prevalence studies.  Whilst there are numerous 
instruments designed to assess experimental studies, the use of tools to assess 
observational studies in systematic reviews is less established (Mallen, Peat & Croft, 
2006).  In a recent review of quality appraisal tools applicable to studies examining 
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prevalence of diseases, Shamliyan, Kane and Dickinson (2010) found existing scales 
and checklists to vary widely and to fall short in a number of key areas: 
discrimination of poor study reporting from methodological quality, distinction 
between internal and external validity and a lack of consistency in terms of reporting 
on tool development as well as reliability.  The authors also noted that most 
numerical scales, where particular weight is allocated to certain items, appeared 
arbitrary (Shamliyan et al., 2010).  In response to this, Hoy et al. (2012) sought to 
develop a rigorous risk of bias tool for prevalence studies by reviewing the existing 
literature, establishing expert consensus and by testing the finalised tool for inter-
rater reliability.  
The Risk of Bias tool (ROBT, Hoy et al., 2012; see Appendix B) consists of 4 
questions relating to external validity: (1) representativeness of target population; (2) 
representativeness of sampling frame; (3) use of random selection; (4) non-response 
bias; and 6 questions relating to internal validity: (5) direct collection of data; (6) 
acceptable case definition; (7) reliability and validity of study instruments 
established; (8) same mode of data collection used for all participants; (9) 
appropriate length of shortest prevalence period; (10) correct reporting of numerator 
and denominator (Hoy et al., 2012).  Question (9) was considered less relevant to this 
review on the basis that ASD is a lifelong developmental disorder and that 
appropriate assessment of psychotic disorders is more important in than the shortest 
prevalence period.  
Each study is rated as ‘high’ or ‘low’ risk of bias in relation to each of the 
nine questions referred to above.  On the basis of these ratings the rater provides an 
overall summary rating for each study, as being subject to low, moderate or high risk 
of bias. Hoy and colleagues reported 93% agreement between raters on the 10 
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individual items of the tool and moderate agreement on the overall rating of studies.  
A summary rating for each included study is presented in Tables 1 and 2.  
Prevalence of psychotic disorders in individuals diagnosed with ASD 
Fourteen studies were included (Table 1), with occurrence of psychosis in 
ASD in ranging from 0% (Ghaziudin, Weidmer-Mikhail & Ghaziudin, 1998; Hutton, 
Goode, Murphy, Le Couteur & Rutter, 2008) to 61.5% (Raja & Azzoni, 2010).   
Type of prevalence.  Studies varied as to the temporal criteria applied when 
estimating prevalence.  Five papers estimated prevalence of psychosis across the 
individual’s lifetime (Buck et al., 2014; Hofvander et al., 2009; Joshi et al., 2013; 
Larsen & Mouridsen, 1997; Mouridsen, Rich, Isager & Nedergaard, 2008), with 
estimates ranging from 5.6% to 34.8%.  Three studies reported prevalence of 
psychosis at a particular point in time, for example, at time of assessment (Buck et 
al., 2014; Joshi et al., 2013) or at time of discharge (Russell, Mataix-Cols, Anson, & 
Murphy, 2005).  Estimates of point prevalence ranged from 5% to 8%.   Five studies 
reported period prevalence of psychosis, including occurrence during a specified 
period preceding or following assessment (Ghaziudin & Zafar, 2008; Ghaziudin et 
al., 1998), occurrence during the period since participants first received their 
diagnosis of ASD (Hutton et al., 2008) or, in two cases, during an unspecified period 
of time (Kohane et al., 2012; Raja & Azzoni, 2010).  Estimates of period prevalence 
in these studies varied from 0% to 61.5%.  In three cases it was not clear which 
temporal criteria were applied when estimating prevalence, which ranged from 4% to 
16% (Billstedt, Gillberg & Gillberg, 2005; Lugengard, Hallerbäck & Gillberg, 2011; 
Stahlberg, Soderstrom, Rastam & Gillberg, 2004).  
Definition of caseness.  Definitions of “psychosis” in these studies varied.  
Two papers specifically stated that no cases of “schizophrenia” were reported 
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(according to ICD-10, Hutton et al., 2008, and DSM-III and DSM-IV, Ghaziudin et 
al., 1998).  Others appeared to assess for any of a spectrum of psychotic disorders 
under ICD or DSM (e.g. Kohane et al., 2012; Mouridsen et al., 2008).  One study 
(Stahlberg et al., 2004) referred expressly to the occurrence of bipolar disorder with 
psychotic features and these cases are included in the reported prevalence rates, 
whereas other studies reported diagnoses of bipolar disorder but made no mention of 
whether such presentation was accompanied by psychotic features (e.g. Joshi et al., 
2013).  Billstedt and colleagues (2005) refer broadly to psychosis as diagnosed by a 
psychiatrist, without reference to any diagnostic criteria.  
Case ascertainment.  Ascertainment of psychosis cases was carried out by a 
variety of methods, ranging from case note review without any face-to-face contact, 
to clinical interview of the individual being assessed with the aid of a structured 
diagnostic tool.  Several studies referred to multiple sources of available information 
in their case ascertainment (e.g. clinical status of the individual, structured interview, 
DSM-IV criteria checklist and informant semi-structured collateral interview, 
Stahlberg et al., 2004).  The Structured Clinical Interview for DSM-IV Axis I 
disorders (SCID-I; First, Gibbon, Williams & Spitzer, 1997) was employed in four 
studies (Hofvander et al., 2009; Joshi et al., 2013; Lugnegard et al., 2011; Stahlberg 
et al., 2004).  Raja and Azzoni (2010) employed the Scale for Assessment of 
Negative Symptoms (SANS; Andreasen, 1983) and the Scale for Assessment of 
Positive Symptoms (SAPS; Andreasen, 1984).  Hofvander et al. (2009) reported 
using a structured DSM-IV based clinical interview to assess participants.  Other 
studies ascertained psychosis cases by means of an informant interview, including 
with the aid of a structured instrument specifically designed to assess psychiatric 
disorders in individuals with developmental difficulties.  Buck et al. (2014) used an 
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abbreviated version of the Psychiatric Assessment Schedule for Adults with 
Developmental Disability (PAS-ADD; Moss et al., 1998) and Hutton et al. (2008) 
utilised the Schedule for Assessment of Psychiatric Problems Associated with 
Autism (SAPPA; Bradley & Bolton, 2006).  Several studies reported carrying out a 
psychiatric examination of the individual being assessed and/or a collateral informant 
interview but did not employ a structured instrument in this process (Billstedt et al., 
2005; Ghaziudin and Zafar, 2008; Ghaziudin et al., 1998), although Ghaziudin et al. 
(1998) do report utilising symptom checklists for DSM-III and DSM-IV.   Four 
studies did not carry out any direct assessment of individuals or informants but 
employed various methods of record review: hospital records (Kohane et al., 2012), 
medical records of psychiatric inpatient admissions (Larsen & Mouridsen, 1997), 
records on a national psychiatric register regarding admissions and consultations 
(Mouridsen et al., 2008) and admission and discharge reports (Russell et al., 2005). 
Sampling methods.  Two studies collected data in the community (Billstedt 
et al., 2005; Buck et al., 2014) and two via multiple institutions (Hofvander et al., 
2009 and Kohane et al., 2012).   The majority of included studies recruited their 
samples via one or two specialist ASD or neuropsychiatric clinics (Ghaziudin & 
Zafar, 2008; Ghaziudin et al., 1998; Hutton et al., 2008; Joshi et al., 2013; Lugnegard 
et al., 2011; Russell et al., 2005; Stahlberg et al., 2004).  Two studies (Larsen & 
Mouridsen, 1997; Mouridsen et al., 2008) collected data in psychiatric clinics and 
one study (Raja & Azzoni, 2010) in a psychiatric intensive care unit.  
27 
 
Table 1   
Summary table of reviewed studies reporting occurrence of psychosis in ASD 
 
Study 
 
n 
 
Country 
 
Sample 
 
IQ 
 
Method of assessing ASD 
and (diagnostic criteria) 
 
 
Method of assessing psychosis 
and (diagnostic criteria) 
 
Prevalence 
(temporal criteria) 
 
Risk of 
bias 
 
Hofvander et al., 
2009* 
 
 
 
122 
 
Sweden and 
France 
 
Two child 
neuropsychiatric 
clinics 
 
One psychiatric 
outpatient clinic 
 
 
 
Normal 
range 
 
Record review, informant 
interview where possible, clinical 
assessment 
 
(DSM-IV / Gillberg & Gillberg 
(1989) criteria for AS) 
 
SCID-I 
or 
Structured, DSM-IV-based, 
clinical interview plus life-time 
DSM-IV symptom checklist 
 
(DSM-IV) 
 
12% 
(lifetime prevalence) 
 
 
 
Low 
 
 
Joshi et al., 2013 
 
63 USA ASD clinic 
 
 
Mixed  Neuropsychological assessment, 
structured diagnostic interview, 
structured diagnostic interview of 
primary caretaker if available.  
 
(DSM-IV) 
 
SCID-I administered to 
individual and informant where 
available 
 
(DSM-IV) 
8%  
(status at time of assessment) 
13%  
(lifetime prevalence) 
 
Low  
 
 
Stahlberg et al., 
2004* 
 
 
129 Sweden Child 
neuropsychiatric 
clinic 
 
 
Mixed Diagnoses based on all available 
information, including clinical 
status of the patient, ASSQ, 
ASDI, and 
DSM-IV criteria checklist. 
Where possible, informant semi-
structured collateral interview. 
 
Diagnoses based on all 
available information, including 
clinical status of the patient, 
SCID-1 and DSM-IV criteria 
checklist. 
Where possible, informant 
semi-structured collateral 
interview. 
7% prevalence of bipolar 
disorder with psychotic 
features 
7.8% prevalence of 
schizophrenia or another 
psychotic disorder 
(ns) 
Low 
 
Billstedt et al., 
2005 
 
 
108 Sweden Community 
 
 
 
 
 
Mixed DISCO and/or record review 
 
(DSM-IV / ICD-10) 
Psychiatric examination and/or 
interview with informant 
(ns) 
7% in autistic disorder group  
9% in atypical autism group  
(ns) 
Medium  
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Study 
 
n 
 
Country 
 
Sample 
 
IQ 
 
Method of assessing ASD 
and (diagnostic criteria) 
 
Method of assessing psychosis 
and (diagnostic criteria) 
 
Outcome 
 
Risk of 
bias 
 
Buck et al., 2014 
 
 
 
129 
 
USA 
 
Community 
 
 
 
Mixed 
 
Record review, historical and 
present symptom forms, current 
mental state examination and 
family interview 
(DSM-III) 
 
Record review 
(DSM-IV) 
 
 
Mini PAS-ADD informant 
interview 
(ICD-10) 
 
 
 
5%  
(status at time of assessment) 
10%  
(lifetime prevalence) 
 
 
Medium  
 
Hutton et al., 
2008 
135 UK ASD clinic Mixed ADI-R and ADOS 
 
(ns) 
Telephone screen with 
informant 
SAPPA informant interview 
(ICD-10) 
 
0%  
(over period since ASD first 
diagnosed) 
Medium 
 
Ghaziuddin & 
Zafar, 2008 
 
 
 
 
28 USA ASD clinic 
 
 
 
 
ns Record review, 
neuropsychological assessment, 
speech and language evaluation, 
psychiatric interview, 
ABC completed by informant 
(DSM-IV) 
 
Psychiatric interview and chart 
review 
(DSM-IV) 
 
7.1%  
(status at time of assessment 
or during previous 12 months) 
High 
 
Ghaziuddin et al., 
1998 
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USA ASD clinic 
 
Normal 
range 
Diagnosis according to ICD-10 / 
DSM-IV criteria 
 
(ICD-10 / DSM-IV) 
 
 
K-SADS-E for participants 
below 17 years of age, record 
review, psychiatric 
examination, symptom 
checklists 
(DSM-III / DSM-IV) 
 
0% prevalence 
(status at time of assessment 
or during 2 year follow-up 
period) 
High 
 
Kohane et al., 
2012 
 
 
ns** 
 
 
 
USA Three general 
hospitals, one 
paediatric 
hospital 
 
 
ns Retrospective hospital record 
review, using Shared Health 
Research Informatics Network 
software, not chart review 
 
(ICD-9 as used by healthcare 
providers for billing) 
Retrospective hospital record 
review, not chart review 
 
(ICD-9 as used by healthcare 
providers for billing) 
8.8%  
(period ns) 
 
 
High 
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Study 
 
n 
 
Country 
 
Sample 
 
IQ 
 
Method of assessing ASD 
and (diagnostic criteria) 
 
 
Method of assessing psychosis 
and (diagnostic criteria) 
 
Outcome 
 
Risk of 
bias 
Larsen & 
Mouridsen, 1997 
 
 
 
18 Denmark Child 
psychiatric 
hospitals 
 
 
Mixed Child psychiatric record review 
 
(ICD-10) 
 
 
 
Medical case records of 
individuals admitted to adult 
psychiatric departments 
 
(ICD-10) 
5.6%  
(lifetime prevalence) 
 
 
High 
 
Lugnegard et al., 
2011 
 
 
54 Sweden Two 
neuropsychiatric 
clinics 
 
Normal 
range 
DISCO-11 
 
(ns) 
 
SCID-I 
(DSM-IV) 
 
4% 
(ns) 
 
High  
 
Mouridsen et al., 
2008 
 
89 Denmark Two child 
psychiatric 
clinics 
 
 
 
Mixed  Psychiatric record review 
(ICD-10) 
 
 
Data extracted from nationwide 
Danish Psychiatric Central 
Register for inpatient 
admissions and outpatient 
consultations 
(ICD-10) 
 
34.8% 
(lifetime prevalence) 
 
 
High 
 
Raja & Azzoni, 
2010 
 
26 Italy Psychiatric 
intensive care 
unit 
 
Mixed Clinical diagnosis based on 
record review and informant 
interview 
(DSM-IV-TR) 
SAPS and SANS 
(DSM-IV-TR) 
 
61.5%  
(period ns) 
High 
 
Russell et al., 
2005 
 
 
40 UK Specialist ASD 
clinic 
Normal 
range 
ADI (where parent available) 
Psychiatric assessment 
(ICD-10) 
Admission / discharge reports 
review 
(ICD-10) 
7.5% 
(status at time of discharge) 
High 
Note. ABC = Autism Behavior Checklist (Krug, Arick & Almond, 1980); ADI-R = Autism Diagnostic Interview-Revised (Lord, Rutter & Le Couteur, 1994); ADOS = 
Autism Diagnostic Observation Schedule (Lord et al., 2000); ASDI = Asperger Syndrome Diagnostic Interview (Gillberg, Gillberg, Rastam & Wentz, 2001);  ASSQ = the 
Asperger Syndrome and high functioning autism Screening Questionnaire (Ehlers & Gillberg, 1993);  DISCO = Diagnostic Interview for Social and Communication 
Disorders (Wing, Leekam, Libby, Gould & Larcombe, 2002); K-SADS-E = Kiddie-Schedule for Affective Disorders and Schizophrenia – Epidemiological Version (Puig-
Antich, Orvaschel, Tabrizi & Chambers, 1980); PAS-ADD = Psychiatric Assessment Schedule for Adults with Developmental Disability (Moss et al., 1998); SANS = Scale 
for Assessment of Negative Symptoms (Andreasen, 1983); SAPPA = Schedule for Assessment of Psychiatric Problems Associated with Autism (Bradley& Bolton, 2006); 
SAPS = Scale for Assessment of Positive Symptoms (Andreasen, 1984); SCID = Structured Clinical Interview for DSM-IV Axis I disorders (First, et al., 1997). 
* Some participants in Hofvander et al. (2009) were also studied in Stahlberg et al. (2004) 
** Total sample in Kohane et al. (2012) was 14,381, which includes adults and children.  Outcome figures reported here are for adults only. 
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Method of assessing ASD.  All studies specify formal diagnostic criteria 
employed when diagnosing ASD, most commonly, DSM-IV (APA, 1994) and ICD-
10 (WHO, 1992), save for two (Hutton et al., 2008 and Lugnegard et al., 2011), both 
of which use diagnostic measures based on ICD-10 or DSM-IV criteria.  Three 
studies employed validated diagnostic measures approved by NICE (2012) as having 
sufficient psychometric evidence to recommend their use in assessing ASD in adult 
populations:  Hutton et al. (2008) used the Autism Diagnostic Observation Schedule 
(ADOS; Lord et al., 2000) and the Autism Diagnostic Interview-Revised (ADI-R; 
Lord et al., 1994), Russell et al. (2005) also used the ADI-R, where an informant was 
available, and Stahlberg et al. (2004) employed the Asperger Syndrome Diagnostic 
Interview (ASDI; Gillberg et al., 2001).  Other studies utilise instruments which are 
not NICE recommended for use with adults due to lack of psychometric evidence but 
are widely used in the clinic, for example, the Diagnostic Interview for Social and 
Communication Disorders (DISCO; Wing et al., 2002) employed by Billstedt et al. 
(2005) and Lugnegard et al. (2011).  Three papers state that a neuropsychological or 
clinical assessment was carried out but do not stipulate use of a particular measure 
(Ghaziudin & Zafar, 2008; Hofvander et al., 2009; Joshi et al., 2013).  Ten studies 
report involving a family member or other informant in the assessment process, 
where possible, as recommended by NICE (2012) guidelines (Billstedt et al., 2005; 
Buck et al., 2014; Ghaziuddin & Zafar, 2008; Hofvander et al., 2009; Hutton et al., 
2008; Joshi et al., 2013; Lugnegard et al., 2011; Raja & Azzoni, 2010; Russell et al., 
2005; Stahlberg et al., 2004).  Three studies rely solely on record reviews in 
conjunction with diagnostic criteria: Kohane et al., 2012; Larsen & Mouridsen, 1997; 
Mouridsen et al., 2008).  Several papers use a combination of the methods referred to 
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above, drawing on multiple sources of available data (e.g. Hofvander et al., 2009; 
Stahlberg et al., 2004).  
Prevalence of ASD in individuals diagnosed with psychotic disorders 
Six studies reported on prevalence of ASD in a population of individuals 
diagnosed with psychosis (Table 2).  Occurrence of ASD in psychosis ranged from 
0.8% (Chang et al., 2003) to 27% (Hallerback, Lugnegard & Gillberg, 2012). 
Type of prevalence.  Whereas the course of psychosis may extend over a 
period ranging from weeks to decades, ASD is considered a lifelong developmental 
disorder.  Prevalence estimates in these studies reflect this and, in general, do not 
distinguish between point, period and lifetime prevalence. 
Definition of caseness.  All studies (excluding Mandell et al., 2012) 
reference specific diagnostic criteria applied in identifying ASD cases.  Three studies 
apply DSM-IV criteria (Chang et al., 2003; Davidson et al., 2013; Fraser et al., 2012) 
and two studies utilise ICD-10 criteria (Hallerback et al., 2012; Nylander & Gillberg 
(2001).   Gillberg’s criteria for Asperger Syndrome (Leekam et al., 2000) are also 
referenced by a number of studies (e.g. Hallerback et al., 2012).  Studies varied as to 
the precise diagnostic categories included in their research.  Both Chang et al. (2003) 
and Fraser et al. (2012) use DSM-IV pervasive developmental disorder diagnoses, 
however, the latter authors exclude Rett’s Disorder and Childhood Disintegrative 
Disorder.   Hallerback et al. (2012) and Nylander and Gillberg (2001) apply ICD-10 
criteria for diagnoses of childhood autism and atypical autism but prefer Gillberg’s 
criteria for Asperger syndrome (AS; Hallerback al., 2012) or diagnose individuals 
meeting ICD-10 criteria for AS with “ASD” (Nylander & Gillberg, 2001).  Davidson 
et al.’s (2013) study focuses exclusively on identifying cases of AS.  Mandell et al. 
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(2012) do not provide a clear definition of ASD although do state that the ADI-R 
diagnostic algorithm (based on ICD-10 and DSM-IV guidelines, Lord et al., 1994) is 
utilised in some cases.  
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Table 2   
Summary table of reviewed studies reporting occurrence of ASD in psychosis 
 
Study 
 
n 
 
Country 
 
Sample 
 
IQ 
 
Method of assessing 
psychosis 
and (diagnostic criteria) 
 
 
Method of assessing ASD 
and (diagnostic criteria) 
 
Prevalence 
 
 
Risk of 
bias 
Hallerback et al., 2012 
 
44 Sweden Adult psychiatric 
clinic 
Normal 
range 
SCID-I 
(DSM-IV) 
DISCO-11 interview with 
informant, AQ, patient record 
review 
(ICD-10) 
27% 
 
Medium 
 
Mandell et al., 2012 123 USA Inpatient 
psychiatric 
hospital 
Mixed SANS-SAPS, review of 
historical charts and 
electronic records using a 
semi-structured 
abstraction process, case 
conference 
(ns) 
 
ADI-R interview with informant 
(only possible in 61 cases), 
review of historical charts and 
electronic records using a semi-
structured abstraction process, 
SRS, case conference 
(ns) 
9.8% Medium 
 
 
Nylander and Gillberg, 
2001 
 
423 Sweden Psychiatric 
outpatient clinic 
Mixed Record review 
(ICD-9) 
ASDASQ completed by the 
primary clinician, record 
review, participant interview, 
informant interview including 
ASSQ and ASDI 
(ICD-10) 
 
1.7% 
 
Medium  
 
Chang et al., 2003 128 Taiwan  Adult psychiatric 
outpatient clinic 
Mixed  ns 
(DSM-IV) 
ASDASQ, individual and 
informant interview 
(DSM-IV) 
0.8%  High  
 
Davidson et al., 2013 197 UK Early 
Intervention in 
Psychosis 
Service 
Normal 
range 
SCI-PANSS 
(ICD-10) 
ASDASQ, case note review, 
diagnostic interview 
(DSM-IV) 
3.6%  
 
High 
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Study 
 
n 
 
Country 
 
Sample 
 
IQ 
 
Method of assessing 
psychosis 
and (diagnostic criteria) 
 
 
Method of assessing ASD 
and (diagnostic criteria) 
 
Prevalence 
 
 
Risk of 
bias 
Fraser et al., 2012 292 Australia Youth mental 
health service 
 
 
ns* 
 
ns 
(ns) 
Treating clinician asked to 
classify participant as having 
been diagnosed with ASD by 
psychiatrist, paediatrician or 
clinical psychologist (based on 
all available records) 
(DSM-IV) 
 
3.4% High 
 
 
Note. ADI-R = Autism Diagnostic Interview-Revised (Lord et al., 1994); AQ = Autism-Spectrum Quotient (Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001); 
ASDASQ = Autism Spectrum Disorder in Adults Screening Questionnaire (Nylander & Gillberg, 2001); ASDI = Asperger Syndrome Diagnostic Interview (Gillberg et al., 
2001); DISCO = Diagnostic Interview for Social and Communication Disorders (Wing et al., 2002); SANS = Scale for Assessment of Negative Symptoms (Andreasen, 1983); 
SAPS = Scale for Assessment of Positive Symptoms (Andreasen, 1984); SCID = Structured Clinical Interview for DSM-IV Axis I disorders (First, et al., 1997); SCI-PANSS 
= Structured Clinical Interview for Positive and Negative Syndrome Scale (Kay, Fiszbein & Opfer, 1987); SRS = Social Responsiveness Scale (Constantino, 2005). 
* Participant IQ not stated in Fraser et al. (2012), however service sampled is stated not to be resourced to cope with moderate or severe LD. 
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Case ascertainment.  Two studies employed validated informant report 
measures recommended by NICE for the assessment and diagnosis of ASD in adults 
(although in both studies this was dependent upon an informant being available for 
interview):  the ADI-R (Lord et al., 1994) was used by Mandell and colleagues 
(2012) and the Asperger Syndrome Diagnostic Interview (ASDI; Gillberg et al., 
2001) was used by Nylander and Gillberg (2001).  One study (Hallerback et al., 
2012) used a case identification instrument approved by NICE for the identification 
of ASD in individuals with IQ in the normal range, the Autism-Spectrum Quotient 
(AQ; Baron-Cohen et al., 2001).  Hallerback and colleagues (2012) also used an 
adapted form of the DISCO-11 (Wing et al., 2002) to interview parents where 
possible, a measure which is not recommended by NICE for the diagnosis of ASD in 
adults but is widely used by clinicians.  Three studies engaged in a screening process 
prior to employing formal diagnostic techniques to assess for ASD, by means of the 
Autism Spectrum Disorder in Adults Screening Questionnaire (ASDASQ; Nylander 
& Gillberg, 2001) in the case of Chang et al. (2003), Davidson et al. (2013) and 
Nylander and Gillberg (2001) and, additionally, by means of a case note review in 
Davidson et al., 2013 and Nylander and Gillberg (2001).  Fraser et al. (2012) 
ascertained cases by asking the primary clinician treating the individual’s psychiatric 
difficulties to classify individuals as falling within DSM-IV diagnostic criteria or not.  
None of the included studies reported employing observational tools (e.g. the ADOS; 
Lord et al., 2000) in their ascertainment of cases.   
Sampling methods.  All the studies recruited their samples in single clinics 
treating individuals for mental health difficulties, excluding Fraser et al. (2012) 
where data were collected across several clinics making up a broader mental health 
service.  
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Method of assessing psychosis.  Two studies did not stipulate diagnostic 
criteria applied in identifying psychosis cases (Fraser et al., 2012; Mandell et al., 
2012).  Other studies reported reference to DSM-IV (Chang et al., 2003; Hallerback 
et al., 2012), ICD-10 (Davidson et al., 2013) or ICD-9 (Nylander & Gillberg, 2001).  
Three studies report employing structured diagnostic tools in a face-to-face 
diagnostic process when assessing for psychosis.  Davidson et al. (2013) used the 
Structured Clinical Interview for Positive and Negative Syndrome Scale (SCI-
PANSS; Kay et al., 1987) and describe the broad definition of psychosis adopted by 
the service sampled: all non-organic psychotic disorders in ICD-10 and unipolar or 
bipolar mood disorders where psychotic symptoms are present.  Hallerback et al. 
(2012) used the SCID-I (First et al., 1997) and report a broad range of SCID 
psychosis subtypes including Bipolar disorder type I.  Mandell et al. (2012) 
employed the Scale for Assessment of Negative Symptoms (SANS; Andreasen, 
1983) and the Scale for Assessment of Positive Symptoms (SAPS; Andreasen, 1984) 
and report diagnoses of schizophrenia, including psychosis not otherwise specified.  
Three remaining studies do not describe the process by which a diagnosis is reached 
at the particular clinics sampled:  Chang et al. (2003) report initial psychiatric 
diagnoses of schizophrenia according to DSM-IV.  Fraser et al. (2012) simply 
describe a diagnostic category of “psychosis” (p. 85).  Nylander and Gillberg (2001) 
refer to registered diagnoses according to ICD-9, grouped as:  schizophrenia or 
paranoid psychosis, acute non-affective psychosis, cycloid psychosis and affective 
psychosis. 
Discussion 
This review aimed to investigate existing literature estimating the co-
occurrence of ASD and psychosis and to assess whether: (i) the prevalence of 
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psychosis may be higher in an ASD population than in the general population; and 
(ii) whether the prevalence of ASD maybe in higher in a psychosis population than in 
the general population.  Current estimates of prevalence of ASD in the general 
population are approximately 1% in both child and adult populations (DSM-5; APA, 
2013a; Baron-Cohen et al., 2009; Brugha et al., 2012).  Such estimates represent an 
increase on rates reported in the 1970s when childhood autism was thought to affect 
only 0.04% of individuals (e.g. Rutter, 1978).  There is uncertainty as to whether 
contemporary estimates of prevalence reflect the broadening of diagnostic criteria, 
greater awareness of the condition, an improvement in methods of diagnosis or a 
genuine increase in the prevalence of ASD (DSM-5; APA, 2013a).  There is also a 
history of variability in the estimated prevalence of schizophrenia in the general 
population.  DSM-IV (APA, 1994) notes that large studies have estimated prevalence 
as ranging from 0.2% to 2% and concludes lifetime prevalence of schizophrenia as 
lying between 0.5% and 1%.  More recently, DSM-5 (APA, 2013a) reduced this 
estimate of lifetime prevalence to between 0.3% and 0.7%.   
The present review found extensive variability in the reported estimates of 
prevalence of psychosis in ASD, ranging from 0% to 61.5% and highlights the 
heterogeneity of studies attempting to investigate this issue.  The studies varied 
widely in terms of both external and internal validity, with differences in sampling 
frame, size of sample, case definition, approach to diagnosis and method of data 
collection.  Quality appraisal suggests that around two thirds of the included studies 
may have a moderate to high risk of bias in estimating the prevalence of psychosis in 
this population.  
Four studies utilising community or multiple clinic samples and benefitting 
from somewhat larger sample sizes report prevalence (other than point prevalence) 
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ranging from 8.8% to 16% (Billstedt et al., 2005; Buck et al., 2014; Hofvander et al., 
2009; Kohane et al., 2012).  Of these, only two studies stipulate the specific type of 
prevalence reported (Buck et al., 2014; Hofvander et al., 2009) with both studies 
estimating lifetime prevalence and reporting rates of 10% and 12% respectively.  
One of these two studies (Hofvander et al., 2009) was considered to have made 
significant attempts to minimise bias such that there was estimated to be a low risk of 
bias associated with this study.  Buck et al. (2014), thought to have a medium risk of 
bias, also provide a point prevalence estimate of 5%.  
Other studies recruited participants from one or two ASD or neuropsychiatric 
clinics and tended to have smaller sample sizes.  Three such studies reported lifetime 
prevalence estimates of:  5.6% (Larsen & Mouridsen, 1997; ascertaining cases via 
record review and utilising a very small sample size, therefore assessed as having a 
high risk of bias), 13% (Joshi et al., 2013; thought to have a low risk of bias) and 
34.8% (Mouridsen et al., 2008; consisting of a record review and assessed as 
incorporating a high risk of bias).  Three studies recruiting from one or two clinics 
reported a range of period prevalence estimates: 0% over the period since first 
receiving an ASD diagnosis (Hutton et al., 2008; assessed as having a medium risk 
of bias), 0% at time of assessment and over a two year follow-up period (Ghaziudin 
et al., 1998; considered to have a high risk of bias) and 7.1% at time of assessment 
and during the previous twelve months (Ghaziudin & Zafar, 2008; also associated 
with a high risk of bias).  Two studies reported similar point prevalence estimates of 
7.5% (Russell et al., 2005; thought to have a high risk of bias) and 8% (Joshi et al., 
2013; assessed as low risk in terms of bias).  Two further such studies reported 
prevalence estimates without stating the type of prevalence investigated:  4% 
(Lugnegard et al., 2011) and 7.8% (or, 14.8% including bipolar disorder with 
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psychotic features; Stahlberg et al., 2004).  Whilst the overall risk of bias in 
Stahlberg et al. (2004) was assessed as being relatively low, the quality of reporting 
in this study would have benefitted from an express statement as to the type of 
prevalence estimated (i.e. point, period or lifetime).  
One study (Raja & Azzoni, 2010), reporting a much higher estimate of 
prevalence than the other studies included here (61.5% prevalence over a period 
which was not specified), sampled a Psychiatric Intensive Care Unit.  This study was 
considered to be associated with a particularly high risk of bias given the highly 
selected nature of this sample in a care setting designed specifically for complex, 
comorbid cases.  
Studies utilising structured diagnostic tools for the ascertainment of psychosis 
cases reported lifetime prevalence estimates of 12% (Hofvander et al., 2009; SCID-I) 
and 13% (Joshi et al., 2013; SCID-I).  Other studies utilising such tools did not 
stipulate the type of prevalence reported and provided estimates of 4% (Lugnegard et 
al., 2011; SCID-I), 61.5% (Raja & Azzoni, 2010; SAPS and SANS) and 14.8%, 
including bipolar disorder with psychotic features, (Stahlberg et al., 2004; SCID-I).   
Assessment of psychosis usually involves direct interaction with the 
individual concerned (NICE, 2014), however two studies utilised structured 
informant interview tools as a means of ascertaining cases of psychosis.  Buck et al. 
(2014), using the Mini PAS-ADD informant interview, estimated lifetime prevalence 
of psychosis to be 10% and Hutton et al. (2008), utilising the SAPPA, estimated the 
occurrence of psychosis over the period since ASD was first diagnosed to be 0%.  
Both these studies recruited individuals with learning difficulties as well as 
individuals assessed as having an IQ in the normal range.  However, the tools utilised 
in these studies were designed specifically for use with individuals with learning 
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difficulties (Mini PAS-ADD, see Buck et al., 2014; SAPPA, see Bradley & Bolton, 
2006) and have not been validated in individuals with normal IQ.   
Other studies used a variety of methods of case ascertainment widely 
employed in the clinic, including psychiatric examination, collateral interview with 
informant and symptom checklists based on diagnostic criteria.  Estimates of 
prevalence were 1 year period prevalence of 0% (Ghaziuddin et al., 1998; assessed as 
having a high risk of bias), 2 year period prevalence of 7.1% (Ghaziuddin & Zafar, 
2008; also thought to have a high risk of bias) and a non-specific prevalence of 16% 
(Billstedt et al., 2005; associated with a medium risk of bias).   
All studies ascertaining caseness by means of a record review process were 
assessed as being associated with a high risk of bias (Kohane et al., 2012; Larsen & 
Mouridsen, 1997; Mouridsen et al., 2008; Russell et al., 2005).  Estimates reported 
ranged from 5.6% to 34.8%.   
Based on studies which appear to have the lowest risk of bias and 
appropriately report the type of prevalence estimated, the lifetime prevalence of 
psychosis in an adult ASD population might be estimated to be around 12-13% (e.g. 
Hofvander et al., 2009; Joshi et al., 2013).  This estimate is significantly higher than 
the lifetime prevalence estimate of schizophrenia in the general population reported 
by DSM-5 (APA, 2013a) of between 0.3% and 0.7%.   
 The studies reviewed here reporting on estimated occurrence of ASD in 
psychosis also reveal considerable variability, with prevalence estimates ranging 
from 0.8% to 27%.  All of the studies sampled single psychiatric clinics or services 
rather than selecting samples from the community.  Definitions of ASD varied 
greatly across studies, with different diagnostic frameworks being applied (DSM-IV, 
ICD-10, Gillberg’s criteria for AS) and studies setting different inclusion criteria in 
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terms of ASD diagnosis sought.  For example, Davidson et al. (2013) aim 
exclusively to identify cases of Asperger’s Disorder (according to DSM-IV criteria) 
and estimate prevalence of 3.6% in their Early Intervention in Psychosis Service 
sample.  They suggest this may be a conservative estimate in view of the screening 
process employed prior to engaging in more thorough assessment.  However, 
Davidson et al.’s (2013) psychosis population is somewhat broader than that of other 
studies, including unipolar or bipolar mood disorders where psychotic symptoms are 
present.  Chang et al. (2003) apply broader ASD criteria, including DSM-IV 
diagnoses of autism, Rett’s Disorder, Childhood Disintegrative Disorder, Asperger’s 
Disorder and PDD-NOS.  Their estimate of prevalence is substantially lower than 
that of Davidson and colleagues (2013) at only 0.8%.  Again, there are concerns as to 
the screening process adopted by Chang et al. (2003) and the lack of validated 
instrument employed in the final stages of case ascertainment.  
 As previously discussed, only two studies utilised assessment tools approved 
by NICE (2012) for the diagnosis of ASD in an adult population and in both studies 
use of such tool depended on the availability of an informant (Mandell et al., 2012; 
Nylander & Gillberg, 2001).  These studies estimated prevalence of ASD as 9.8% 
and 1.7% respectively and were thought to be associated with a medium level of risk 
of bias.  Hallerback et al. (2012), who use a NICE-approved case identification 
instrument and then the DISCO-11 to interview informants where available, estimate 
prevalence at the higher rate of 27%.   The remaining studies utilised case 
ascertainment methods that have not been recommended by NICE as constituting 
reliable means of identifying cases of ASD and report prevalence estimates ranging 
from 0.8% to 3.6% (Chang et al., 2003; Davidson et al., 2013; Fraser et al., 2012). 
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 Based on these six included studies investigating occurrence of ASD in a 
psychosis population, it is difficult to arrive at a solid estimate of prevalence.  
Mandell et al.’s (2012) estimate of 9.8% is based on an inpatient psychiatric sample 
where complex, comorbid cases are likely to be more prevalent than in an outpatient 
clinic and therefore might be expected to constitute an overestimate.  However, 
Hallerback and colleagues (2012) estimate significantly higher rates of prevalence 
(27%) in their sample, which they consider to be reasonably representative of all 
individuals with psychosis in the county of Värmland, Sweden.  Given the small 
number of included studies, the relatively high risk of bias associated with the studies 
and their heterogeneity (particularly in terms of the specific ASD diagnoses included 
and the diagnostic criteria applied), meaningful comparison of reported figures is 
challenging.  Effective assessment of ASD in adults involves gathering a range of 
information from multiple sources and NICE (2012) recommended structured 
assessment tools tend to be costly and time-consuming.  As such, it is perhaps not 
surprising that studies estimating prevalence of ASD in a psychosis population are 
heterogenous and associated with considerable risk of bias.  Nevertheless, in order 
for a meaningful prevalence range to be estimated, further studies are required 
benefitting from community samples, consistency in terms of the definition of ASD 
cases (e.g. ASD as defined by DSM-5; APA, 2013a) and utilising ‘gold standard’, 
NICE (2012) guideline approved adult assessment tools. 
This review suggests that symptoms of psychosis may be more prevalent in 
individuals with ASD than in the general population.  Research has sought to 
uncover factors which might explain such co-occurrence, including: (i) the 
possibility that the two disorders share the same aetiological underpinnings; (ii) the 
hypothesis that ASD is a separate disorder but constitutes a risk factor for developing 
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psychotic symptoms; and (iii) the possibility that, in a proportion of cases, there is no 
real co-occurrence of ASD and psychosis, rather the symptoms of ASD have been 
misconstrued as psychotic. 
Whilst there are known risk factors contributing to each of ASD and 
psychotic disorders, how such factors fit together to cause each disorder has not been 
established and in many cases a complex interaction of genetic and environmental 
factors is likely to be involved (NICE, 2014; NICE, 2012).  Environmental risks 
implicated in the aetiology of both ASD and psychotic disorders may include such 
factors as advanced parental age, maternal infection during pregnancy and low birth 
weight (DSM-5, APA 2013a; Cheung et al., 2010).   
Genes are known to constitute a significant risk factor in both ASD and 
psychosis (NICE, 2012; NICE, 2014).  However, in the majority of cases, such risk is 
thought to be polygenic, with multiple genetic loci making a small contribution 
(DSM-5; APA, 2013a; Sullivan, Kendler & Neale, 2003).  Crespi et al. (2010), 
evaluating hypotheses explaining the genomic relationship between ASD and 
schizophrenia, found evidence to support partial overlap and diametric models of this 
relationship, but discounted the hypothesis that the two disorders are completely 
independent of one another, arguing that the overlap in genetic factors between them 
is greater than would be expected by chance.   A diametric model of these two 
disorders was proposed by Crespi and Badcock (2008), who suggest that ASD and 
schizophrenia exist at either end of the same continuum of sociocognition.  They 
argue that autism spectrum disorders reflect a bias towards the effects of paternally 
expressed genes, contributing to brain overgrowth and underdevelopment of social 
brain systems, manifesting in the theory of mind deficits characteristic of ASD.  The 
underpinnings of psychotic disorders, on the other hand, are suggested to involve 
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biases towards the effects of maternally expressed genes, which mediate a general 
pattern of undergrowth and an overdevelopment of social brain systems, that is, a 
tendency to ‘over-mentalise’ (e.g. paranoia).  A partial overlap model is evidenced 
(as discussed previously) by the presence of genomic risk factors common to both 
disorders, including duplications, deletions and particular alleles associated with 
ASD and schizophrenia (Crespi et al., 2010).  
Both ASD and the psychotic disorders are associated with sociocognitive 
deficits, such as impaired theory of mind (Frith & Corcoran, 1996; Holroyd & 
Baron-Cohen, 1993; Sprong, Schothorst, Vos, Hox & Van Engeland, 2007).  ‘Theory 
of mind’ or ‘mentalising’ is the ability to appreciate the existence of an individual’s 
subjective state of mind (thoughts, beliefs, intentions) and to understand and predict 
behaviour on the basis of this appreciation.  Studies have sought to uncover shared 
mechanisms underlying such social cognitive dysfunction in the two disorders.  For 
example, Pinkham, Hopfinger, Pelphrey, Piven and Penn (2008), found significantly 
reduced neural activation of certain discrete brain regions involved in sociocognitive 
processing in an ASD group and a paranoid schizophrenia group as compared to a 
healthy comparison group whilst completing a task of complex social cognition.  
However, other studies have highlighted the heterogeneity in the neuroanatomical 
findings in the autism and schizophrenia literature (Sasson et al., 2011) and, over all, 
there has been a failure to show definitively why these areas of overlap occur.   
An alternative possibility is that ASD and psychosis do not share overlapping 
aetiological processes but that ASD itself constitutes a risk factor for the 
development of psychotic symptoms in later life.  NICE (2014) highlights 
psychological factors implicated in the development of psychotic symptoms, 
including problems with basic cognitive functions (such as learning, attention, 
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memory and planning) and biases in emotional and reasoning processes.  ASD is 
known to be associated with deficits in these domains, for example, in executive 
functioning, central coherence, mindblindness and a lack of preferential attention to 
social stimuli contributing to difficulty reading emotions from face and voice (Frith 
& Happe, 2005).  Such psychological characteristics commonly found in individuals 
with ASD may generate a particular vulnerability to developing symptoms of 
psychosis.  The experience of growing up with a neurodevelopmental disorder such 
as ASD is also associated with broader psychosocial risk factors implicated in the 
development of psychotic symptoms, for example, childhood adversity including 
neglect and bullying (NICE, 2014).  
A number of the studies reviewed here consider the possibility that symptoms 
of ASD have been misinterpreted as psychotic (e.g. Davidson et al., 2013; Raja & 
Azzoni, 2010).  The overlap in symptomatology between the two disorders (e.g. 
socio-cognitive deficits, restricted interests, flattening of affect) has been noted.  In 
addition, studies suggest that symptoms traditionally considered to be typical of 
psychotic disorders may also feature in ASD.  For example, Raja and Azzoni (2010) 
suggest that hallucinations and delusions are inappropriately excluded from 
definitions of ASD and Dossetor (2007) highlights the presence of thought disorder 
in ASD and other conditions impacting language development.   The diagnostic tools 
employed in the ascertainment of cases of autism spectrum and psychotic disorders 
may not be sophisticated enough to distinguish between the two conditions.  
Bastiaansen et al. (2011) reported limitations in the ability of module 4 of the ADOS 
to differentiate between individuals with ASD and those with schizophrenia 
characterised by negative symptoms.  Nylander, Lugnegard and Hallerback (2008) 
suggest that the diagnosis of psychotic symptoms relies particularly heavily on an 
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individual’s ability to communicate, which may hinder accurate diagnosis in 
individuals with the communication difficulties associated with ASD.  
A number of limitations should be held in mind when considering the 
findings of this review.  It was discovered that certain studies investigating the co-
occurrence of ASD and psychosis did not include a term relating to ‘psychosis’ or 
‘schizophrenia’ in their titles, abstracts or keywords, utilising instead the broader 
term ‘psychopathology’ to indicate an investigation into the occurrence of a range of 
psychiatric disorders in ASD.  Whilst a number of such studies were discovered (for 
example, in the reference lists of included papers) it is possible that some relevant 
studies may have been missed due to the parameters of this particular systematic 
search.  In addition, many of the studies included here provide prevalence estimates 
based on samples with mixed IQ scores making it difficult to distinguish between the 
impact of ASD and the impact of learning difficulty.  It was not possible, due to 
restrictions of time and resource, to employ two researchers to evaluate papers 
identified by the search for relevance and to appraise the quality of the included 
studies independently, allowing for an assessment of interrater reliability of such 
judgements.  As such, quality ratings reported in this review are subjective, and the 
reliability with which inclusion criteria were applied is untested.  However, the 
ROBT was designed specifically for the assessment of prevalence studies and 
demonstrated good interrater reliability in Hoy and colleagues’ findings (2012).  
This review highlights a need for additional research in a number of areas.  
Well-designed epidemiological research, in particular large scale, population based, 
prospective studies, to provide a reliable estimate of co-occurrence of ASD and 
psychosis, is currently lacking. The validation of a measure designed specifically for 
the assessment of psychotic symptoms in an adult ASD population may also assist in 
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establishing the true prevalence of psychosis in this population.   Given the 
heterogeneity of both autism spectrum and psychotic disorders, nosological 
considerations may also continue to need to be refined, to clarify which symptoms 
occur in both disorders and why.  Improved detection of and/or distinction between 
ASD and psychosis is of vital importance.  There is a need for valid and reliable 
ASD assessment tools that are capable of distinguishing between symptoms of ASD 
and those of other psychiatric disorders including psychosis.  In particular, informant 
report measures for the assessment of ASD in adults would provide vital information 
as to the individual’s childhood development and their functioning prior to onset of 
psychiatric symptoms.  Such tools are likely to improve therapeutic strategies in the 
clinic and allow for targeted treatment of individuals, including those experiencing 
co-occurrence.  This in turn will enable clinicians to improve the functioning and 
quality of life of individuals experiencing these disorders.   
The reported findings have clinical implications.  Clinicians working in ASD 
and psychosis services need to be mindful of the possibility of an association 
between these two disorders.  On the one hand, care should be taken in the 
assessment process, to distinguish between subtle overlapping symptoms to avoid 
misdiagnosis.  On the other hand, clinicians working in an ASD setting should 
consider the possibility that having ASD may constitute a risk factor for the 
development of psychotic symptoms and engage in watchful waiting and provide 
targeted support where appropriate.  Psychosis services should consider the 
possibility that a diagnosis of ASD may have been missed in individuals presenting 
in the clinic.  Where there is doubt as to an individual’s symptomatology clinicians 
should aim to carry out a detailed assessment process which takes into account a 
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person’s early childhood development.  It is hoped that accurate diagnosis will allow 
for more effective treatment.   
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Abstract 
Background.  There is a lack of validated tools for the assessment of autism 
spectrum disorder (ASD) in an adult population.  Such tools need to function 
effectively in the face of complex clinical presentations seen in adult psychiatric 
services, that is, to unravel symptoms of ASD from those of comorbid mental health 
difficulties or from those of alternative psychiatric disorders with an overlapping 
symptom profile.  The Dimensional, Developmental and Diagnostic Interview – 
short version for adults (3Di-sva) is a new, informant-report instrument consisting of 
71 questions designed to gather a comprehensive history of an individual from early 
childhood to current functioning.  The measure generates scores for subscales 
reflecting DSM-5 diagnostic criteria for ASD. 
Aims. This study aimed to evaluate the psychometric properties of the 3Di-sva, 
including by assessing its ability to discriminate between adults with ASD and those 
diagnosed with other clinical disorders.  The psychometric properties of an 
abbreviated version of the 3Di-sva algorithm, consisting of 49 questions focusing 
exclusively on the current functioning of the individual (3Di-sva current algorithm) 
were also examined.  
Methods. The 3Di-sva was administered to a parent or other relative of 27 adults 
diagnosed with ASD and 20 clinical comparison adults with a range of mental health 
disorders.  Where possible, estimated IQ data were collected from participants (ASD 
n=17, comparison n=17) and informant interviews were audio-recorded and 
independently coded to assess inter-rater reliability (ASD n=10, comparison n=19).   
Results. This study found the full length 3Di-sva to be a reliable measure, 
demonstrating good interrater reliability and acceptable to good internal consistency.  
The full length 3Di-sva also showed good general criterion validity as assessed in the 
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context of this sample:  ASD participants scored significantly higher than clinical 
comparison participants on all subscales of the measure, large effect sizes were 
found, and sensitivity (0.85) and specificity (0.90) were high.  The 3Di-sva current 
algorithm was also found to have good interrater reliability and the majority of the 
subscales demonstrated good internal consistency.  The current algorithm was found 
to have good criterion validity, with ASD participants scoring significantly higher 
than clinical comparison participants on all subscales.  Sensitivity (0.85) and 
specificity (0.95) were found to be high.  
Conclusions.  This study provides promising evidence that the 3Di-sva is a well 
validated, reliable informant report instrument for the diagnosis of autism spectrum 
disorders in adults.  It has been shown adequately to discriminate ASD from other 
mental health difficulties in an adult population.  It is time-efficient and easy to 
administer.  In future it will be important to examine the psychometric properties of 
the 3Di-sva when used in a more ecologically valid diagnostic setting, such as an 
adult ASD assessment clinic, where all individuals being assessed are suspected of 
having an autism spectrum disorder.  Future research should also investigate the 
reliability and validity of the 3Di-sva with discrete clinical comparison groups of 
individuals diagnosed with specific mental health disorders, as well as assessing the 
psychometric properties of the current algorithm when used with informants who did 
not know the individual in childhood, for example, carers or friends.  
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Introduction 
Autism spectrum disorders (ASD) are lifelong neurodevelopmental disorders 
characterised by (i) difficulties in social communication and interaction across a 
range of contexts, and (ii) restricted, repetitive behaviours and interests (Diagnostic 
and Statistical Manual of Mental Disorders, 5
th
 ed.; DSM-5; American Psychiatric 
Association [APA], 2013a). Symptoms must manifest in early childhood, although 
these may not be recognised until later in life when social demands exceed an 
individual’s abilities, and must cause functional impairment.  Diagnosis is made on 
the basis of these behavioural criteria since no specific and reliable biological 
markers have been identified in ASD (Medical Research Council, 2001).   
The conceptualisation of ASD has evolved considerably since Leo Kanner 
first published his observations of a group of children displaying marked difficulties 
with social interaction and repetitive behaviour in 1943.  Historically, autism was 
widely regarded as a psychotic disorder (DSM-II, APA, 1968) and was attributed 
exclusively to environmental factors, such as, a cold parenting style (Bettleheim, 
1967).  In the 1970s, Michael Rutter’s research (1978) identified certain key features 
of autism as a distinct disorder, symptoms present in virtually all children diagnosed 
with autism and rarely found in children without autism, namely severely impaired 
social skills, language delay and stereotyped behaviours or routines.  Rutter (1978) 
also highlighted evidence for autism as a neurodevelopmental disorder, including 
physiological symptoms associated with autism, such as epilepsy, and the 
concordance of autism in identical twins.  This was reflected in DSM-III (APA, 
1980) which described a new class of disorder, the “pervasive developmental 
disorders”, to which the diagnosis of “infantile autism” was assigned.  DSM-III-R 
(APA, 1987) revised the definition of infantile autism to that of “autistic disorder” 
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and set out three key areas of impairment:  (i) reciprocal social interaction; (ii) 
communication; and (iii) restricted interests.   
Autism spectrum disorders continued to be conceptualised according to this 
triad of impairments until the publication of DSM-5 (APA, 2013a) when the separate 
dimensions of social interaction and communication were collapsed into a single 
category, reflecting research evidencing the construct validity of a dyadic model of 
ASD (e.g. Mandy, Charman & Skuse, 2012).  In addition to introducing the autism 
dyad, DSM-5 replaced three separate autism sub-diagnoses set out in DSM-IV-TR 
(autistic disorder, Asperger’s disorder, and pervasive developmental disorder not 
otherwise specified; APA, 2000) with a single disorder:  autism spectrum disorder.   
This reflected concerns about the reliability of these ASD subtypes, with research 
suggesting that they were not consistently distinguished from each other by clinicians 
(APA, 2013b).  The current spectrum conceptualisation accounts for the variability in 
presentation of individuals with ASD by acknowledging that different presentations 
sit along a continuum from mild to very severe and that ASD can present with or 
without language and/or intellectual disability (APA, 2013b). 
The spectrum construct is also consistent with challenges to the traditional 
concept of ASD as a categorically distinct disorder which manifests qualitatively 
differently from other clinical disorders and from a typically developing presentation 
(Constantino & Todd, 2003; Medical Research Council, 2001; Wing, 1988).  There 
is evidence that the behavioural characteristics required for a diagnosis of ASD may 
in fact represent an extreme manifestation of traits which appear continuously in the 
general population (Posserud, Lundervold & Gillberg, 2006).   
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Estimates of the prevalence of ASD have also evolved since the 1970s when 
it was thought to be a fairly rare condition, present in only 4 per 10,000 children 
(Rutter, 1978).   Contemporary childhood prevalence studies estimate occurrence to 
be approximately 1% of the population (Baird et al., 2006; Baron-Cohen et al., 2009) 
and suggest that for every three known cases of ASD there will be two undiagnosed 
individuals who may require assessment and support later in life (Baron-Cohen et al., 
2009).  This increase in the number of reported cases of ASD is thought to reflect 
greater public awareness, a broadening of diagnostic criteria and screenings for the 
disorder becoming more common (Chakrabarti & Fombonne, 2005).   Prevalence of 
ASD in adulthood is estimated to be similar to that in children, at approximately 
1.1% of the UK population (Brugha et al., 2012), contradicting any idea that people 
may ‘grow out of’ ASD and further countering the suggestion that ASD is becoming 
more prevalent. Studies of outcomes in adulthood confirm that individuals diagnosed 
with ASD in childhood remain disadvantaged in a range of domains, with few 
estimated as being able to function completely independently (e.g. Howlin & Moss, 
2012).      
Notwithstanding increased awareness of the condition, there is evidence that 
some individuals with ASD reach adulthood without ever receiving a diagnosis 
(Geurts & Jansen, 2011; Nylander & Gillberg, 2001).  Ritvo, Ritvo, Freeman and 
Mason-Brothers (1994) suggest that individuals with mild or late-manifesting 
symptoms are less likely to present in the clinic until adolescence or adulthood and 
that these individuals present a particular diagnostic challenge to clinicians.  ASD 
symptoms tend to fluctuate across the lifespan (Matson & Neal, 2009; Vannucchi et 
al., 2014), with important life events and transitions affecting the way in which 
symptoms present across the individual’s development, yet the majority of 
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assessment tools were designed specifically with children in mind (National Institute 
for Health and Clinical Excellence [NICE], 2012).  In addition, ASD shares 
significant overlap in symptomatology with other conditions, such as psychosis and 
mood disorders, which may lead to misdiagnosis (Rutter, 2013; Vannucchi et al., 
2014).  The diagnostic picture is further complicated by the fact that individuals with 
ASD are at increased risk of experiencing comorbid mental health difficulties, such 
as mood and anxiety disorders, (Geurts & Jansen, 2011; Skokauskas & Gallagher, 
2010).  ASD symptoms may be misattributed to such coexisting conditions.   
Given the complexity associated with diagnosing ASD in adults, it is not 
surprising that studies have highlighted the struggle faced by adults in accessing a 
diagnosis (Taylor & Marrable, 2011).   Adults with ASD are reported to suffer 
exclusion both socially and economically, with services often failing to identify the 
condition and provide appropriate support (NICE, 2012).  In their review of follow-
up studies on adults with ASD, Howlin and Moss (2012) concluded that adults with 
ASD are at increased risk of poor outcomes in terms of employment, social 
relationships, quality of life and physical and mental health.  Diagnosis is vital in 
enabling individuals to receive much needed support from health and social services.  
However, charities such as The National Autistic Society describe adults struggling 
for years to obtain a diagnosis and even then finding that the diagnosis is challenged 
by services (The National Autistic Society, 2010).  An understanding of the 
characteristics of the disorder, which may be facilitated by receipt of a diagnosis, can 
also help families and carers understand the individual’s needs, behaviours and 
responses. 
In recent years the UK government has recognised the need for improved 
diagnostic and care pathways for ASD.  The Autism Act (2009) provided for 
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statutory guidance to be published setting out actions required by councils and health 
authorities to meet the needs of individuals with ASD in their local area.  The 
resulting guidance (Department of Health, 2010) makes recommendations for the 
development of a clear and consistent pathway to diagnosis in every locality.  The 
National Institute for Clinical Excellence endorses such a policy in its guideline for 
ASD in adults (NICE, 2012) which emphasises the need to capture patients through 
diagnosis and recommends the creation of specialist multi-agency teams to cater for 
this client group. 
Effective assessment of ASD in adults involves obtaining a broad range of 
information from multiple sources in a diagnostic battery.  It should include:  enquiry 
as to the presence of core symptoms of ASD since childhood, a developmental 
history if possible, an assessment of the individual’s functioning in a range of 
environments, such as home, education and employment, and understanding whether 
the individual may be hyper- or hypo-sensitive to sensory input (NICE, 2012).  Such 
information is traditionally gathered by three means - self-report, direct observation 
and informant report – often with the aid of structured assessment tools (NICE, 
2012).   
Self-report tools provide valuable information as to the lived experience of 
the individual being assessed.  The Ritvo Autism and Asperger Diagnostic Scale: 
Revised (RAADS-R; Ritvo et al., 2011) is a self-report tool recommended for use in 
the assessment of adults by NICE (2012) demonstrating good psychometric 
properties.  It has been shown to have good internal consistency and test-retest 
reliability, as well as excellent sensitivity (97%) and specificity (100%), (Ritvo et al., 
2011).  However, concerns raised regarding the impact that psychological and 
cognitive deficits associated with ASD may have on an individual’s insight into his 
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or her own symptoms (Bishop & Seltzer, 2012; Johnson, Filliter & Murphy, 2009) 
mean that self-report tools are rarely used in isolation.   
Direct observation of the individual in situations designed to elicit behaviours 
relevant to a clinical diagnosis of ASD is a fundamental element of a comprehensive 
assessment process.  The Autism Diagnostic Observation Schedule (ADOS; Lord et 
al., 2000) is a widely used observational measure and has a module designed 
specifically for use with verbally fluent adults (module 4).  It is the only 
observational tool recommended by NICE (2012) for use with adults.  It is a well 
validated instrument, which has been shown to be reliable (Lord et al., 2000) and to 
demonstrate good sensitivity and adequate to good specificity (Hus & Lord, 2014).  
Concerns have been raised as to the ability of module 4 of the ADOS to distinguish 
between individuals with ASD and those with schizophrenia characterised by 
negative symptoms (Bastiaansen et al., 2011).  Revisions to the module 4 algorithm 
in the ADOS-2 (Lord et al., 2012) were designed to achieve better differentiation 
between these groups, however further research is needed to confirm this (Hus & 
Lord, 2014).   Extensive training is required before the ADOS can be administered 
and it is expensive to acquire, which may have resource implications in clinical 
settings (Charman & Gotham, 2013; NICE, 2012). 
NICE (2012) recommends the involvement, where possible, of a family 
member or other informant in the assessment process in order to obtain information 
as to the individual’s past and current behaviour and childhood development.  
However, adult-specific informant report measures for the assessment of ASD are 
currently lacking.   
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The Autism Diagnostic Interview-Revised (ADI-R; Lord, Rutter & Le 
Couteur, 1994) is a semi-structured interview originally designed for use with the 
parents of children with suspected ASD.  It demonstrates good sensitivity and 
specificity (Lord et al., 1994) and has been assessed by NICE (2012) as having 
satisfactory reliability and validity data.  Whilst NICE (2012) does recommend use 
of the ADI-R with adult populations, it highlights the fact that there are no data 
assessing the reliability or the construct and criterion validity of the ADI-R with 
adults.  The ADI-R is also time-consuming to administer, taking up to three hours 
(Matson, Nebel-Schwalm & Mastson, 2007), and requires extensive and costly 
training prior to use.  
The Diagnostic Interview for Social and Communication Disorders (DISCO; 
Wing, Leekham, Libby, Gould, & Larcombe, 2002) was also designed for use in the 
assessment of children and is distinctive in that it reflects a dimensional approach to 
the autism spectrum rather than focusing specifically on diagnostic categories set out 
in ICD (e.g. ICD-10; World Health Organisation, 1992) or DSM (e.g. DSM-IV-TR; 
APA, 2000).  However, psychometric evidence as to use of the DISCO with adults is 
limited and therefore NICE (2012) does not recommend its use as a diagnostic tool in 
adult populations.  In addition, as with the ADI-R, administration of the DISCO is a 
lengthy process (two to four hours; Charman & Gotham, 2013) which impacts on its 
utility in a clinical setting.  
Two further informant report tools recommended by NICE (2012) are the 
Adult Asperger Assessment (AAA; Baron-Cohen, Wheelwright, Robinson, & 
Woodbury-Smith, 2005), and the Asperger Syndrome Diagnostic Interview (ASDI; 
Gillberg, Gillberg, Rastam & Wentz, 2001). The AAA, in recognition of the 
limitations of existing assessment instruments created for use with children, was 
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designed specifically for use with adults (Baron-Cohen et al., 2005) and the 
psychometric properties of the ASDI have been assessed in a population which 
includes adults (Gillberg et al., 2001).  However, both these instruments were 
designed for the assessment of individuals with suspected Asperger Syndrome or 
High Functioning Autism and therefore do not measure the full range of ASD 
presentations described in DSM-5 (APA, 2013a).  In addition, further research as to 
the validity and reliability of these instruments is needed.  Currently only one 
published paper exists in respect of each instrument (Baron-Cohen et al., 2005; 
Gillberg et al., 2001) and these are authored by the original developer of the 
instrument and utilise relatively small sample sizes.  
In view of the limitations in the quality of psychometric evidence for the use 
of existing informant report tools with adults and the practical constraints (such as, 
administration time, training and cost) associated with such tools, there is a need for 
a new ASD informant report measure to be designed and validated.  Clinics with 
limited resources require an informant report measure which is user-friendly, time-
efficient and easily accessible in terms of cost and training, as well as reliable and 
valid in adult populations. 
 The Dimensional, Developmental and Diagnostic Interview (3Di; Skuse et 
al., 2004) is a further standardised informant report measure, currently used in the 
assessment of ASD in children and adolescents.   Whereas the ADI-R and the 
DISCO were designed primarily to assess individuals with below average IQ, the 3Di 
is capable of assessing autistic characteristics in children with either normal range 
abilities or with moderate or severe learning difficulties (Skuse et al., 2004).  This 
approach reflects contemporary research suggesting that approximately half of 
individuals meeting criteria for ASD have an IQ in the normal range (Baird et al., 
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2006).   Responding to the evolution in the conceptualisation of ASD from a 
categorically distinct disorder to an extreme manifestation of traits which exist 
continuously in the general population, the 3Di was also devised to assess autistic 
characteristics dimensionally in both ASD and non-ASD populations (Skuse et al., 
2004).  Accordingly, the 3Di can indicate the presence of autistic traits in individuals 
who do not meet full diagnostic criteria for ASD, and was also devised to assess 
mental states relevant to potential comorbid diagnoses, potentially providing 
extremely useful information for tailored interventions (Skuse et al., 2004).  
 The 3Di originally consisted of 113 items, however a shorter version was 
later developed (3Di-sv; Santosh et al., 2009) which consists of just 53 items. The 
3Di-sv has been shown to be valid and reliable for use with child populations 
(Santosh et al., 2009).  As the age of participants in the study conducted by Santosh 
and colleagues ranged from 2.4 – 21.1 years (mean= 9.9, SD=3.3), this research 
raised the question of whether the instrument may also be suitable for use with 
adolescents and young adults.   
The 3Di-sv was recently adapted to create a specific adult version of the 
interview (Dimensional, Developmental and Diagnostic Interview – Short Form 
Adult Version; 3Di-sva).  Items for inclusion in the 3Di-sva were selected from the 
3Di-sv based on their ability to discriminate between individuals with and without 
ASD in older adolescents.  Certain of these items were then amended to ensure the 
question made sense when applied to an adult, for example, when asking a question 
about childhood behaviour, clarifying that this took place in the past:  
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“When [name] was at primary school, did he ask if he could invite friends 
over?”  New items were also added to reflect specific features of the ASD phenotype 
in adults, based on expert clinical opinion, for example:   
“Have there been times when [name] has been easily led by others, resulting 
in (him/her) getting into trouble?”   
More recently, items have been added to reflect the new diagnostic criteria for ASD 
set out in DSM-5 (APA, 2013a), including the emphasis on unusual sensory 
responses:   
“Is (he/she) ever distressed by everyday sounds, such as, the noise of a 
vacuum cleaner, food processor or hand dryer?”. 
The 3Di-sva includes 71 questions aimed at gathering a comprehensive history 
ranging from early childhood development to current functioning.  The interview can 
be completed in 45 minutes and individuals can be trained in its administration in 
around an hour.  Scoring can be carried out using a computer algorithm.  
A pilot study to validate the 3Di-sva in ASD and typically developing adult 
populations has been carried out.  These initial data are promising, showing that the 
3Di-sva is able to discriminate effectively between typically developing adults and 
adults with an ASD.   However, further research is required to provide a more 
detailed assessment of the validity and utility of the tool.  The pilot study 
investigated the psychometric properties of an older version of 3Di-sva designed to 
reflect the triadic characterisation of ASD set out in DSM-IV-TR (APA, 2000).  The 
3Di-sva algorithm has since been updated to reflect the reconceptualisation of ASD 
as a dyad of impairments in DSM-5 (APA, 2013a).  In addition, given the high 
prevalence of comorbid mood and anxiety disorders in individuals with ASD (Geurts 
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& Jansen, 2011) and the significant overlap in symptomatology between ASD and 
schizophrenia (Bastiaansen et al., 2011; Sprong, Schothorst, Vos, Hox & Van 
Engeland, 2007), it is important to assess the ability of the 3Di-sva to discriminate 
accurately between adults with ASD and adults with other psychiatric presentations.  
This represents a more difficult and ecologically relevant test of the measure’s 
criterion validity. 
The current study aims to analyse the psychometric properties of the 3Di-sva 
by examining the reliability, criterion validity, and sensitivity and specificity of the 
measure.  Criterion validity of the measure will be assessed by examining its ability 
to discriminate between individuals diagnosed with ASD and individuals without 
ASD who have been diagnosed with other clinical disorders.  A concurrent study 
(Clarke, 2015), completed jointly with this project, investigated the ability of the 
3Di-sva to discriminate between individuals with ASD and those with no clinical 
history.   
Given that adults presenting with suspected ASD do not always have easy 
access to an informant who knew them well in childhood, this study also aims to 
assess the psychometric properties of an alternative scoring algorithm for the 3Di-
sva, which only takes into consideration questions about the individual’s behaviour 
currently and excludes questions about childhood  (3Di-sva current algorithm).  The 
reliability, criterion validity, and sensitivity and specificity of the 3Di-sva current 
algorithm will be assessed. 
Research questions 
1. Is the 3Di-sva a reliable measure, as demonstrated by good: 
(i) interrater reliability, and  
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(ii) internal consistency? 
2. Does the 3Di-sva have criterion validity, as demonstrated by its ability to 
discriminate effectively between adults with ASD and adults with other clinical 
disorders on each of the two dimensions of ASD identified by DSM-5 (APA, 2013a), 
(i) social communication and interaction, and (ii) restricted, repetitive patterns of 
behaviour, interests or activities? 
3. What is the optimal cut-off threshold for the 3Di-sva in distinguishing between 
ASD cases and non-ASD cases in a psychiatric population, maximising sensitivity 
and specificity of the measure? 
4. In respect of the 3Di-sva current algorithm: 
(i) does the 3Di-sva current algorithm demonstrate good interrater reliability 
and internal consistency?  
(ii) does the 3Di-sva current algorithm discriminate effectively between 
adults with ASD and adults without ASD but with other clinical disorders? 
(iii) what is the optimal cut-off threshold for the 3Di-sva current algorithm in 
distinguishing between ASD cases and non-ASD cases in a psychiatric 
population, maximising sensitivity and specificity of the measure? 
Method 
Design 
 A cross-sectional, between subjects design was used to assess the 
psychometric properties of the 3Di-sva when used with individuals with ASD and 
individuals with other mental health difficulties.  
Joint thesis 
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This thesis formed part of a joint research project and was completed with 
fellow UCL trainee clinical psychologist, Kiri Clarke (Clarke, 2015).  See Appendix 
C for further details of individual contributions to the research.  
Participants 
Sample 
Three samples were recruited between August 2014 and June 2015 for the 
joint research project with Clarke (2015): a group of individuals diagnosed with ASD 
(ASD group), a group of individuals without ASD but diagnosed with other mental 
health difficulties (clinical comparison group) and a group of individuals without 
ASD or other mental health difficulties (non-clinical comparison group).   Analyses 
in respect of the non-clinical comparison group were carried out by Clarke (2015).  
Analyses in respect of the ASD and clinical comparison groups were conducted in 
this study.   
Inclusion and exclusion criteria 
All participants were required to:  1) be aged 18 or over, 2) have a reported 
estimated IQ of 70 or above, that is, in the “average” range (where IQ data were not 
obtained, IQ was assumed to be in the “average” range), and 3) have a parent or 
other informant willing to complete the 3Di-sva.   
Additional inclusion criteria for the ASD group were: 1) the individual was 
assessed by means of an ADOS, module 4, and achieved the cut-off scores for autism 
spectrum classification, and 2) a diagnosis of ASD was reached by clinical consensus 
on the basis of all available data, applying DSM-IV-TR criteria for autistic disorder 
or Asperger’s disorder, or DSM-5 criteria for autism spectrum disorder.  Meeting 
ADOS assessment criteria for ASD was considered a prerequisite for inclusion in the 
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ASD group to ensure that the diagnosis had been established by means of a ‘gold 
standard’ ASD assessment tool.  Formal diagnosis of ASD was then confirmed by 
the clinical team on the basis of all elements of a comprehensive assessment process 
(NICE, 2012) and to protect against the possibility of false positive diagnoses 
pursuant to the ADOS.    
Individuals were included in the clinical comparison group if they had 
received a clinical diagnosis of a mental health disorder.  In fifteen cases formal 
diagnoses were reported directly to the researchers by the appropriate NHS team.  In 
four cases diagnoses were reported by the participants themselves and it was not 
possible to verify the information with the clinicians who provided such diagnoses.  
In the case of one participant recruited via the IAPT service, the exact diagnosis was 
unknown, although it was known that the individual had received cognitive 
behavioural therapy at the service.  Participants were excluded from the clinical 
comparison group if: 1) there were any concerns that the individual may have ASD 
and such concerns had not been excluded following a clinical assessment, 2) the 
researcher collecting informed consent assessed the individual as lacking mental 
capacity to consent, 3) the participant or participant’s parent had insufficient English 
language fluency to be able to understand the relevant measures and interview 
questions (due to there being insufficient resources to provide an interpreter).  
Individuals recruited from the IAPT service were excluded if their only diagnosis at 
the time was one of Post-Traumatic Stress Disorder, as another research project was 
recruiting such participants at the time. 
Sample characteristics 
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The ASD group consisted of 27 participants aged 18-59 and the clinical 
comparison group of 20 participants aged 21-50.  Individuals in the clinical 
comparison group had received a range of mental health disorder diagnoses:  mixed 
anxiety and depression (n=7), depression (n=4), anxiety (n=4), borderline personality 
disorder (n=2), psychotic disorder (n=1), anger and interpersonal difficulties (n=1).  
The diagnosis of one individual attending a step 3 IAPT service was unknown. 
Characteristics of the ASD and clinical comparison groups are presented in Table 1.   
The aim was to recruit a minimum of 20 participants (and a parent or other 
informant in each case) to each group.  This figure was based on similar numbers 
recruited in studies attempting to validate comparable measures (e.g. Bastiaansen et 
al., 2011; Lord et al., 1994) and on practical limitations, such as time and resources.  
Numbers in this study were not based on a power analysis since differences between 
the groups were expected to be large and the study was not concerned with the 3Di-
sva’s capacity to detect small, subtle between-group differences.   
  
77 
Table 1  
Characteristics of the sample 
 Whole 
sample
 
ASD group
 
Clinical 
comparison  
group
 
 
Significance of 
group  
difference 
 N=47*
 
n=27*
 
n=20* 
 
 
 
Number of males (%) 
 
24 (51.1%) 18 (66.7%) 6 (30.0%) X
2
(1) = 6.18, p = .01 
 
Mean age in years (SD) 
Range 
 
 
33.83 (12.10) 
18-59 
 
35.63 (13.32) 
18-59 
 
31.26 (9.90) 
21-50 
 
U = 221.50, z = -.78,  
p = .43 
 
Estimated IQ‡ (SD) 
Range 
 
 
108.55 (14.85) 
72-138 
 
 
109.47 (16.89) 
72-138 
 
107.64 (12.96) 
88-134 
 
t(32)=0.36, p=.73 
 
Years of  
education (SD) 
Range 
 
 
17.15 (2.74) 
11-25 
 
17.60 (2.01) 
14-20 
 
16.88 (3.12) 
11-25 
 
t(25)=0.65, p=.52 
Note:  * Due to missing data: N ranges from 27-47 for the whole sample and n ranges from 10-27 for 
the ASD group and from 17-20 for the clinical comparison group. 
‡ Estimated IQ data were obtained for 17 ASD participants and 17 clinical comparison participants.  
IQ is based on TOPF scores in all but eight of these cases; two ASD participants were assessed using 
the WASI and six ASD participants were assessed using the WAIS-IV. 
Recruitment Procedure 
 Participants in the ASD group were recruited from two adult ASD assessment 
clinics in London (see Figure 1).   
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Figure 1. ASD group recruitment flowchart. 
Historical cases from Clinic 1 with 
consent to research 
 
n=16 
Not eligible for 
inclusion due to 
ADOS score under 
threshold 
 
n=1 
Eligible for 
inclusion, IQ 
estimate 
available 
 
n=3 
No response 
(i.e. did not 
complete 
TOPF) 
 
n=7 
Responded and 
completed 
TOPF 
 
 
n=5 
New cases 
consenting to 
research at Clinic 1 
 
n=15 
New cases 
consenting to 
research at Clinic 2 
 
n=5 
Eligible for 
inclusion 
 
 
n=10 
Total number of cases included in research (ASD group) 
 
N=27 
Not eligible for 
inclusion n=3 
 
Due to: 
No diagnosis 
of ASD given  
n=0 
Diagnosis 
given but 
ADOS score 
under threshold 
n=3 
Not eligible for 
inclusion n=5 
 
Due to: 
No diagnosis 
of ASD given  
n=4 
Diagnosis 
given but 
ADOS score 
under threshold 
n=1 
Eligible for 
inclusion, no IQ 
estimate, contacted 
to provide TOPF 
 
n=12 
 
Eligible for 
inclusion 
 
 
n=2 
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Both services conduct a clinical interview and administer a battery of tests as part of 
the assessment procedure, including the ADOS module 4, an assessment of IQ and, 
where there is an informant available, the 3Di-sva as a means of obtaining richer data 
as to an individual’s developmental history and current presentation across a range of 
contexts.  Decisions around diagnosis are reached by consensus of the 
multidisciplinary team of clinical psychologists and consultant psychiatrists. Twelve 
participants were recruited in the clinic at the time of their ASD assessment.  Fifteen 
participants who had received their ASD diagnosis prior to commencement of this 
study (ASD research database participants) had consented at the time to the use of 
anonymised data for the purpose of research.  Where there were no IQ data on record 
for the ASD research database participants, they were approached by a researcher 
and asked to complete the Test of Premorbid Functioning (TOPF; Wechsler, 2009).   
Participants in the clinical comparison group were recruited from a number of 
sources: 1) individuals with severe and enduring mental health difficulties were 
recruited from secondary care community mental health services in London, 2) 
individuals clinically assessed as having an affective disorder were recruited from an 
IAPT service in London, 3) opportunistic recruitment of individuals currently 
receiving treatment for mental health difficulties who contacted the researchers after 
hearing about the study, and 4) individuals assessed by one of the ASD assessment 
clinics referred to above, where an ASD diagnosis was excluded and a diagnosis of 
other mental health difficulties was given.   Of the four individuals recruited from 
secondary care services, two were approached by a researcher directly in the clinic 
waiting room and two were notified of the research project by a clinician involved in 
the individual’s care.  The participants recruited from IAPT services were on a 
database of individuals consenting to be contacted in relation to research projects.  
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The researchers wrote to individuals on this database, inviting them to participate in 
the project.  Eight participants responded and completed their participation. Four 
individuals were recruited to the study from the ASD clinic at the time of their 
assessment there.   These participants were allocated to the clinical comparison group 
following a clinical consensus as to a diagnosis of mental health disorder rather than 
an ASD diagnosis best explaining their difficulties.  The remaining four participants, 
were recruited opportunistically to the clinical comparison group after hearing about 
the project directly from the researchers or from friends of the researchers.    
Ethics 
Ethical approval for this study was granted by the Bloomsbury NRES 
Committee (Ref 14/LO/1134) and by the Research and Development departments of 
NHS trusts in which participants were recruited (Appendix D).  Prior to taking part, 
individuals (other than ASD research database participants) were given an electronic 
or hard copy of the information sheet setting out details of the study (Appendix E).  
All individuals were asked to provide written, informed consent prior to participating 
(see Appendix F).  In the case of ASD research database participants, consent to the 
use of anonymised data in research projects was obtained at the time they attended 
the clinic for their ASD assessment.  All personal data collected in connection with 
this project was stored and utilised in accordance with the Data Protection Act 1988.  
See Appendix G for invitation letter sent to ASD research database participants and 
Appendix H for invitation letter sent to individuals on the IAPT database. 
Measures 
Developmental, Diagnostic and Dimensional Interview (Short Form Adult Version) 
(3Di-sva) (Appendix I) 
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The 3Di-sva is a semi-structured interview for the assessment and diagnosis 
of autism spectrum disorders in adults.  The interview is designed to be conducted 
with a parent of the individual being assessed, or with another informant who has 
known the individual well since childhood.  It asks questions about early childhood 
development as well as current behaviour, providing a dimensional assessment of the 
areas of autistic impairment highlighted by DSM-5 (APA, 2013a).   
The 3Di-sva interview consists of 71 questions.  Sixty seven of these 
questions contribute to the full length scoring algorithm, whilst the remaining four 
questions relate to developmental milestones.  Forty nine of the 67 questions 
constituting the full length scoring algorithm relate to the individual’s behaviour as 
an adult, whereas eighteen questions relate to behaviours manifesting in childhood 
and rely on the informant having fairly detailed knowledge of the individual growing 
up.  Algorithm questions contribute to one of two scales, reflecting the two key 
domains of symptomatology associated with ASD as cited in DSM-5 (APA, 2013a):  
the “A scale” assesses the individual’s social interaction and communication skills 
and the “B scale” assesses restricted, repetitive patterns of behaviour, activities or 
interests.  Within the A and B scales are 3 and 4 subscales (respectively), reflecting 
the criteria set out in DSM-5.  The full length 3Di-sva scales and subscales are 
displayed in Figure 2. 
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Figure 2. 3Di-sva full length scoring algorithm. 
Questions contributing to the scoring algorithm are scored on a three or four 
point Likert scale (from 0 to 2 or 0 to 3) with higher scores indicating greater 
impairment. The remaining questions, relating to developmental milestones, are 
scored as either within, or outside of, the normal range. To ensure that all items 
within a scale carry equal weight, responses scoring 3 are recoded to a score of 2. 
Total scores for each of the seven subscales are calculated by summing the scores for 
all applicable questions and then dividing by the total number of questions to create a 
scaled score for each subscale of between 0 and 2.  Overall scores for the A-scale 
(Social Communication) and the B-scale (Restricted repetitive behaviour, interests or 
activities) are then generated. As can be seen in Figure 2, a much greater number of 
questions contributes to the A scale subscales than the B scale subscales.  Scaling the 
A-scale: Social communication 
and interaction 
 
B-scale: Restricted, repetitive 
patterns of behaviour, 
interests or activities 
 
A1: Social emotional reciprocity 
14 questions 
 
A2: Deficits in nonverbal behaviour used 
for social interaction 
17 questions 
 
A3: Deficits in forming, maintaining and 
understanding relationships 
18 questions 
 
B1: Stereotyped or repetitive movements  
3 questions 
B3: Restricted fixated interests 
5 questions 
 
B4: Abnormal sensory response 
5 questions 
 
B2: Insistence on sameness 
5 questions 
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subscale scores as explained above ensures that each subscale carries equal weight. 
See Appendix J for a complete copy of the full length scoring algorithm. 
3Di-sva - current algorithm 
An alternative scoring algorithm was developed for the purposes of this 
study, called the 3Di-sva current algorithm.  Only the 49 questions relating the 
individual’s current, as opposed to childhood, behaviour contribute to this 3Di-sva 
current algorithm, whereas scores for the 18 3Di-sva questions which relate to the 
individual’s childhood development and childhood behaviours are excluded.  The 
structure of the 3Di-sva current algorithm is displayed in Figure 3.  As with the 
algorithm for the complete 3Di-sva, scores contribute to the A and B scales and 
subscales within them.  See Appendix K for a complete copy of the current scoring 
algorithm. 
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Figure 3. 3Di-sva current scoring algorithm. 
Autism Diagnostic Observation Schedule (ADOS-G) Module 4 (Lord et al., 2000) 
and ADOS Diagnostic Observation Schedule 2 (ADOS-2) Module 4 (Lord et al., 
2012) 
The ADOS is a standardised semi-structured assessment tool used in the 
diagnosis of ASD.  It consists of questions and activities designed to elicit 
behaviours associated with ASD, assessing language and communication, reciprocal 
social interaction, imagination and stereotyped behaviours and restricted interests.  
Module 4 of the ADOS was designed for use with verbally fluent older adolescents 
and adults.  It focuses less on play activities (as with modules designed for younger 
children) and more on conversation with the individual being assessed.  Module 4 
A-scale: Social communication 
and interaction 
 
B-scale: Restricted, repetitive 
patterns of behaviour, 
interests or activities 
 
A1: Social emotional reciprocity 
10 current questions 
 
A2: Deficits in nonverbal behaviour used 
for social interaction 
17 current questions 
 
A3: Deficits in forming, maintaining and 
understanding relationships 
9 current questions 
 
B1: Stereotyped or repetitive movements  
3 current questions 
B3: Restricted fixated interests 
3 current questions 
 
B4: Abnormal sensory response 
4 current questions 
 
B2: Insistence on sameness 
3 current questions 
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takes around 45-60 minutes to administer.  In this study two different versions of the 
ADOS were used: the ADOS-G (in 11 cases) and the more recent ADOS-2 (in 17 
cases).  Scoring algorithms in the two versions of the ADOS are directly comparable.  
On the basis of observations made and notes taken during administration of 
the ADOS, behaviours are rated on a 0-2 or 0-3 scale, with higher scores indicating 
greater symptom severity.  These ratings are converted to algorithm scores to 
calculate overall scores for the domains of (i) communication and (ii) social 
interaction. Each of these domain scores, as well as the combination of those two 
scores, must meet or exceed a predetermined cut-off in order for a diagnosis of ASD 
to be considered.   Imagination/creativity and stereotyped behaviours and restricted 
interests scores are also generated but these do not count towards the diagnostic 
algorithm.  These data can then be used in conjunction with other available 
information as part of a gold-standard ASD assessment.  The ADOS is a well 
validated instrument with good psychometric properties (Charman & Gotham, 2013; 
Lord et al., 2000).   
Test of Premorbid Functioning – UK version (TOPF; Wechsler, 2009) 
The TOPF is a brief measure of full scale IQ for individuals aged 16 to 89 
years. The test involves reading out loud a list of up to 70 words that have atypical 
grapheme to phoneme translations.  If the individual pronounces five consecutive 
words incorrectly the test is stopped at that point.  The TOPF takes around 5-10 
minutes to complete. The individual’s full scale IQ score is predicted based on the 
number of words pronounced correctly, the number of years spent in education and 
the individual’s age. The TOPF provides an estimate of pre-morbid intellectual 
ability and is designed not to be affected by symptoms of mental health disorders, 
such as lack of motivation, which might impact performance.  The TOPF has been 
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shown to be a reliable measure:  it was found to have a high level of internal 
consistency (0.95) in the UK standardisation sample and to demonstrate good test-
retest reliability (0.89-0.95) in the US standardisation sample (Wechsler, 2009).  The 
TOPF also performs well when predicting full scale IQ as estimated by the Wechsler 
Adult Intelligence Scale-fourth edition (WAIS-IV; Wechsler, 2008), particularly 
when used in combination with demographic variables (correlation of 0.81 in the UK 
standardisation sample).  The TOPF has been validated for use in a range of 
populations including individuals with ASD. 
Procedures 
3Di-sva interviews 
All interviewers conducting the 3Di-sva in this study had been trained in its use.  
Interviews for the clinical comparison group were conducted by the researchers.   
Interviews for the ASD group were carried out by a researcher (n=10) or, in the case 
of all historic ASD research database participants as well as two newly recruited 
participants, by a clinician at the ASD clinic where the individual was being assessed 
(n=17).    The majority of interviews in respect of clinical comparison participants 
were conducted over the telephone (n=17); the remaining three interviews were 
carried out in person, at the mental health or ASD clinic where the participant had 
been recruited.  Interviews in respect of newly recruited ASD participants were 
carried out in person at the ASD clinic (n=7) or over the telephone (n=5).  The 
method of administration in respect of ASD research database participants is 
uncertain, although clinicians reported that the majority were administered in person.  
Interrater reliability   
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An undergraduate psychology student, trained in the 3Di-sva, was recruited 
as a research assistant to assist with the assessment of interrater reliability.  
Interviews were audio-recorded by the researchers where possible (ASD group n=10, 
clinical comparison group n=19) and these recordings were provided to the research 
assistant for the purposes of independent scoring.  The research assistant was blind as 
to which group the recording related to.   
Assessment of cognitive abilities 
Attempts were made to obtain estimated IQ data in respect of all participants 
so that the groups could be compared in terms of IQ levels.  Where IQ data had not 
already been obtained as part of their clinical assessment, participants in the ASD 
group were asked to complete a TOPF with one of the researchers (n=9).  Existing 
IQ assessment data were used in respect of eight individuals in the ASD group.  
Assessment tools used in these cases were the WASI (Wechsler, 1999; n=2) and the 
WAIS-IV (Wechsler, 2008; n=6).  TOPF data were collected from participants in the 
clinical comparison group where possible (n=17).   
Assessment of ASD 
 All individuals in the ASD group were assessed for ASD using module 4 of 
the ADOS.  Four participants in the clinical comparison group were also assessed for 
ASD using the ADOS but were found not to have ASD and were given other mental 
health diagnoses.  
Thanking participants for their time 
Participants and informants in the clinical comparison group were each given 
a £10 voucher to thank them for their time.  It was decided not to offer participants in 
the ASD group vouchers because their data were collected as part of the routine 
88 
clinical assessment and it was thought to be unethical to pay some individuals 
attending the clinic when others would not be offered this opportunity. 
Analyses 
 Statistical Package for Social Sciences (SPSS Version 22) was used to 
perform all analyses.   
Preliminary analyses.  Variables were screened to assess for normality of 
distribution.  Differences between the two groups on age, gender, estimated IQ and 
years of education were also analysed.   
Internal consistency.  For each of the scales and subscales of the 3Di-sva, 
Cronbach’s alpha was calculated. 
Interrater reliability.  Interrater reliability of the interview scores on each of the 3Di-
sva scales and subscales was assessed using intraclass correlation coefficients 
(ICCs).  
Criterion validity.  The ability of the 3Di-sva to discriminate between the ASD group 
and the clinical comparison group was assessed using Mann Whitney U tests.  The 
tests were used to detect statistically significant differences between the groups on A 
scale (social communication and interaction) and B scale (restricted repetitive 
patterns of behaviour, interests or activities) scores, as well as on each of the 
subscales.  Where there were missing data, subscale scores were prorated using the 
mean item score, provided no more than 50% of the data were missing.  
Sensitivity and specificity.  Receiver operating characteristic (ROC) analysis was 
used to establish optimal cut-offs for the 3Di-sva in distinguishing ASD cases from 
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non-ASD cases in a psychiatric population, maximising sensitivity and specificity of 
the measure.  
3Di-sva current algorithm.  3Di-sva scale and subscale scores were re-calculated for 
all participants using the 3Di-sva Current Algorithm and the analyses outlined above 
were conducted in respect of these scores.  
Results 
Preliminary Analyses 
Normality of distribution 
For each group of participants, variables of age, estimated IQ and years of 
education were screened to assess for normality of distribution.  Variables were 
examined visually and the Kolmogorov-Smirnov test of normality was carried out in 
each case.  Distribution of age varied significantly from normality in both the ASD 
(D(27)=.17, p=.04) and the clinical comparison groups (D(20)=.17, p=.04).  
Distribution of estimated IQ and years of education was normal in both groups.  
The distribution of 3Di-sva full algorithm scales and subscales was also 
examined by means of visual examination and the Kolmogorov-Smirnov test.  
Kolmogorov-Smirnov test results are presented in Table 2.  All scales in the clinical 
comparison group and in the combined group were found to deviate significantly 
from normality; distributions were positively skewed due to a greater proportion of 
scores falling at the bottom end of the scale.  In the ASD group all scales were 
distributed normally, other than subscale B2. 
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Table 2 
Kolmogorov-Smirnov test for normality of distribution of 3Di-sva variables 
3Di-sva scale / subscale ASD group
 
Clinical comparison 
group
 
 
Whole sample 
A scale D(27)=.09, p=.20  D(20)=.33, p<.001*** 
 
D(47)=.17, p=.001** 
 
A1 
 
D(27)=.10, p=.20 D(20)=.26, p=.001** D(47)=.16, p=.006** 
 
A2 
 
D(27)=.16, p=.094 D(20)=.31, p<.001*** D(47)=.13, p=.046* 
 
A3 
 
D(27)=.13, p=.20 D(20)=.30, p<.001*** D(47)=.15, p=.007** 
 
B scale 
 
D(27)=.08, p=.20 D(20)=.23, p=.008** D(47)=.14, p=.021* 
 
B1 
 
D(26)=.13, p=.20 D(20)=.49, p<.001*** D(46)=.26, p<.001*** 
 
B2 
 
D(27)=.23, p=.001** D(20)=.38, p<.001*** D(47)=.19, p<.001*** 
 
B3 
 
D(27)=.12, p=.20 D(20)=.26, p=.002** D(47)=.15, p=.011* 
 
B4 
 
D(27)=.13, p=.20 D(20)=.36, p<.001*** D(47)=.19, p<.001*** 
 
*     deviation from normality significant at p<.05 level 
**   deviation from normality significant at p<.01 level 
*** deviation from normality significant at p<.001 level 
 
 Analyses in respect of non-normally distributed variables were carried out by 
means of non-parametric statistical tests.  
Differences between the groups 
Differences between the ASD and clinical comparison groups on age, gender, 
estimated IQ and years of education were also analysed.  There were no significant 
differences between the two groups in terms of age (U = 221.50, z = -.78, p = .43), 
estimated IQ (t(32)=0.36, p=.73) or years of participant education (t(25)=0.65, 
p=.52).  However, there was a significant difference in the proportion of males in 
each group (X
2
(1) = 6.18, p = .01), with 67% of participants in the ASD group being 
male compared to 30% of participants in the clinical comparison group. 
Analyses in respect of the 3Di-sva full algorithm 
Internal consistency 
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Cronbach’s alpha correlation coefficients were computed for each of the scales and 
subscales of the 3Di-sva full algorithm (Table 3).  All scales were found to be in the 
good to excellent range, excluding subscale B1 (α = 0.67; stereotyped repetitive 
movements or speech) which fell slightly below the minimum recommended 
Cronbach’s alpha coefficient of 0.7 (Kline, 2000).   Cronbach’s alpha for each item 
of the scales was also examined to assess whether deletion of an item would 
significantly improve Cronbach’s alpha coefficient for the relevant scale.  As the 
deletion of an item did not improve Cronbach’s alpha by more than 0.02, no specific 
item was considered to impact sufficiently upon a scale’s Cronbach’s alpha to justify 
its deletion.  
Interrater reliability 
Intraclass correlations were high, with each of the 3Di-sva full algorithm 
scales and subscales yielding ICCs in excess of 0.9 (Table 3).  
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Table 3  
Internal consistency and interrater reliability of each scale and subscale of the 3Di-sva, full 
algorithm 
 
3Di-sva full algorithm 
scale / subscale 
 
Internal consistency  
(Cronbach’s α) 
 
 
Interrater reliability 
(ICC) 
 
  
N=47‡ 
 
N=28† 
Social communication and interaction 
(‘scale A’) 
 
0.97 
 
0.99* 
 
 
Social emotional reciprocity (subscale A1) 
 
 
0.86 
 
0.99* 
 
Deficits in non-verbal behaviour used for 
social interaction (subscale A2) 
 
 
0.91 
 
0.98* 
Deficits in forming, maintaining and 
understanding relationships (subscale A3) 
 
 
0.94 
 
0.98* 
 
 
Repetitive interests (‘scale B’) 
 
 
0.93 
 
0.99* 
 
 
Stereotyped repetitive movements or 
speech (subscale B1) 
 
0.67 
 
0.97* 
 
Insistence on sameness (subscale B2) 
 
 
0.86 
 
0.98* 
 
 
Restricted fixated interests (subscale B3)        
 
 
0.79 
 
0.96* 
 
 
Abnormal sensory response (subscale B4) 
 
0.80 
 
0.93* 
Note:  ‡  Due to missing data: N ranges from 21-45 for internal consistency analysis.  
†  A sample of 29 participant 3Di-sva interviews were assessed for interrater reliability.  Due 
to missing data N ranges from 27-28 for this analysis. 
* p < 0.001 
Criterion validity 
 Mean scores obtained by the ASD group and the clinical comparison group 
on each 3Di-sva full algorithm scale and subscale are displayed in Table 4.   Mann 
Whitney U tests show that the ASD group scored significantly higher than the 
clinical comparison group on all nine of the scales.  All effect sizes are above the 
r=.5 threshold for a large effect (Field, 2005).  
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Table 4  
Differences in 3Di-sva full algorithm scores between groups (N=47) 
 
Scale / subscale of the  
3Di-sva full algorithm  
 
Range‡ 
 
ASD 
 
n=27† 
 
Clinical 
comparison 
group 
 
n=20 
 
Significance 
 
Effect size 
Social communication and interaction (scale A) 
Mean (SD) 
Median 
 
0-6 
 
 
3.07 (0.74) 
3.04 
 
 
0.74 (0.97) 
0.26 
 
U = 33.00, z = -5.10, p < .001 
 
 
 
r = -0.74 
Social emotional reciprocity (A1) 
Mean (SD) 
Median 
0-2  
1.07 (0.27) 
1.08 
 
0.26 (0.39) 
0.12 
 
 
U = 45.00, z = -4.86, p < .001
 
 
r = -0.71 
Deficits in non-verbal behaviour used for  
social interaction (A2) 
Mean (SD) 
Median 
 
0-2  
 
0.92 (0.41) 
0.80 
 
 
0.18 (0.28) 
0.00 
 
 
U = 36.00, z = -5.07, p < .001 
 
 
r = -0.74 
Deficits in forming, maintaining and 
understanding relationships (A3) 
Mean (SD) 
Median 
 
0-2  
 
1.08 (0.29) 
1.00 
 
 
 
0.30 (0.34) 
0.17 
 
 
 
U = 28.00, z = -5.21, p < .001 
 
 
r = -0.76 
Repetitive interests (Scale B) 
Mean (SD) 
Median 
0-8  
4.06 (2.12) 
4.33 
 
0.65 (0.79) 
0.37 
 
 
U = 35.50, z = -5.06, p < .001 
 
r = -0.74 
 
Stereotyped repetitive movements or speech (B1) 
Mean (SD) 
Median 
0-2  
0.91 (0.63) 
1.00 
 
 
 
0.08 (0.24) 
0.00 
 
U = 60.00, z = -4.67, p < .001 
 
r = -0.69 
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Scale / subscale of the  
3Di-sva full algorithm  
 
Range‡ 
 
ASD 
 
n=27† 
 
Clinical 
comparison 
group 
 
n=20 
 
Significance 
 
Effect size 
Insistence on sameness (B2) 
Mean (SD) 
Median 
0-2  
1.30 (0.58) 
1.40 
 
0.22 (0.36) 
0.00 
 
 
U = 43.00, z = -4.98, p < .001 
 
r = -0.73 
Restricted fixated interests (B3) 
Mean (SD) 
Median 
 
0-2  
1.08 (0.63) 
1.00 
 
0.20 (0.30) 
0.10 
 
U = 53.50, z = -4.71, p < .001 
 
r = -0.69 
Abnormal sensory response (B4) 
Mean (SD) 
Median 
 
0-2  
0.79 (0.65) 
0.80 
 
0.15 (0.21) 
0.00 
 
U = 111.50, z = -3.51, p < .001 
 
r = -0.51 
‡ Higher score signifies greater impairment 
† Due to missing data, n ranges from 26-27
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 Distribution of ASD group and clinical comparison group scores are 
displayed on the A scale (Figure 4) and on the B scale (Figure 5).  
 
Figure 4.  Distribution of ASD and clinical comparison group scores on the A scale 
of the 3Di-sva full length algorithm 
 
Figure 5.  Distribution of ASD and clinical comparison group scores on the B scale 
of the 3Di-sva full length algorithm 
Receiver Operating Characteristic (ROC) analysis  
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The 3Di-sva full algorithm was able accurately to discriminate between ASD 
cases and clinical comparison cases for each domain of the dyad of autistic 
impairments as measured by the A and B scales, with both areas under the curve 
exceeding 0.93 (Figure 6). The A scale was found to have AUC = .94 (SE=.04), 
p<.001, 95% CI [.86, 1.0] and the B scale, AUC = .93 (SE=.03), p<.001, 95% CI 
[.87, 1.0].  
 
Figure 6.  ROC curve of the 3Di-sva full algorithm A scale (AUC= .94) and B scale 
(AUC=.93) 
Optimal cut-offs for the 3Di-sva full algorithm, selected to maximise 
sensitivity and specificity of the measure, were as follows: a scaled score of 2.1 on 
the A scale (range 0-6) and a scaled score of 1.0 on the B scale (range 0-8).  In order 
to meet the 3Di-sva full algorithm threshold for a diagnosis of ASD an individual 
must meet the scoring cut-off on both scales, in accordance with DSM-5 diagnostic 
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criteria.  The proportion of cases correctly identified by the 3Di-sva full algorithm as 
having ASD is displayed in Table 5.  
Table 5  
Participant diagnoses identified by the 3Di-sva full algorithm 
 
Participant Group 
 
 
3Di-sva diagnosis 
  
ASD 
 
Non-ASD 
 
 
ASD  
 
23 4 
 
Clinical 
Comparison 
 
2 18 
 
These thresholds yielded a sensitivity (the probability that the 3Di-sva full 
algorithm will correctly detect a positive case of ASD) value of 0.85 (95% CI [.66, 
.96]) and a specificity (the probability that the 3Di-sva full algorithm will correctly 
identify non-ASD cases) value of 0.90 (95% CI [.68, .99]).  The positive predictive 
value of the 3Di-sva full algorithm (representing the probability that ASD is present 
when the algorithm result is positive) was found to be 0.92 (95% CI [.74, .99]) in the 
current sample.  The negative predictive value in this sample (the probability that 
ASD is not present when the full algorithm yields a negative result) was 0.82 (95% 
CI [.60, .95]).  
Analyses in respect of the 3Di-sva current algorithm 
Normality of distribution 
The distribution of each 3Di-sva current algorithm scale and subscale was 
examined by means of visual examination and the Kolmogorov-Smirnov test.  
Kolmogorov-Smirnov test results are presented in Table 6. 
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Table 6   
Kolmogorov-Smirnov test for normality of distribution of 3Di-sva current algorithm 
variables 
 
3Di-sva scale 
/ subscale 
ASD group
 
Clinical comparison 
group
 
 
Whole sample 
A scale D(27)=.12, p=.20  D(20)=.30, p<.001*** 
 
D(47)=.15, p=.01* 
 
A1 
 
D(27)=.13, p=.20 D(20)=.28, p<.001*** D(47)=.14, p=.02* 
 
A2 
 
D(27)=.16, p=.09 D(20)=.31, p<.001*** D(47)=.13, p=.046* 
 
A3 
 
D(27)=.16, p=.06 D(20)=.23, p=.006** D(47)=.15, p=.011* 
 
B scale 
 
D(27)=.10, p=.20 D(20)=.22, p=.014* D(47)=.14, p=.016* 
 
B1 
 
D(26)=.13, p=.20 D(20)=.49, p<.001*** D(46)=.26, p<.001*** 
 
B2 
 
D(27)=.23, p=.001** D(20)=.38, p<.001*** D(47)=.22, p<.001*** 
 
B3 
 
D(27)=.21, p=.003** D(20)=.38, p<.001*** D(47)=.19, p<.001*** 
 
B4 
 
D(26)=.16, p=.10 D(20)=.36, p<.001*** D(46)=.23, p<.001*** 
 
*     deviation from normality significant at p<.05 level 
**   deviation from normality significant at p<.01 level 
*** deviation from normality significant at p<.001 level 
 
As with the full 3Di-sva algorithm, all scales in the clinical comparison group 
and in the combined group were found to deviate significantly from normality when 
applying the current algorithm.  In the ASD group all 3Di-sva current algorithm 
scales were distributed normally, other than subscales B2 and B3.  Analyses in 
respect of non-normally distributed variables were carried out by means of non-
parametric statistical tests. 
Internal consistency  
Cronbach’s alpha correlation coefficients were computed for each of the 
scales and subscales of the 3Di-sva current algorithm (Table 7).  All scales were 
found to be in the good to excellent range, excluding the following subscales: B1 (α 
= 0.67; stereotyped repetitive movements or speech), B3 (α = 0.62; restricted, fixated 
interests) and B4 (α = 0.69; abnormal sensory response).  These three B subscales 
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fell below the minimum recommended Cronbach’s alpha coefficient of 0.7 (Kline, 
2000).    
Cronbach’s alpha for each item of the scales was also examined to assess 
whether deletion of an item would significantly improve Cronbach’s alpha 
coefficient for the relevant scale.  Within the B subscales, item L30 (Does s/he 
include over-precise information in his/her talk; r=.28) from subscale B3 and item 
I64 (Has [Name] ever seemed unusually interested in things that spin; r=.26) from 
subscale B4 were both found to have low item total correlations. Deletion of item 
L30 from subscale B3 would have improved Cronbach’s alpha (from α = 0.62 to α = 
0.71).  Deletion of item I64 from subscale B4 would also have improved Cronbach’s 
alpha (from α = 0.69 to α = 0.74).  However, it was felt that removal of these items 
would have significantly compromised the content validity of the 3Di-sva current 
algorithm, by limiting its coverage of DSM-5 diagnostic criteria.  Accordingly the 
items were retained.   
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Table 7  
Internal consistency and interrater reliability of each scale and subscale of the 3Di-sva 
current algorithm 
 
 
3Di-sva scale / subscale 
 
Internal consistency  
(Cronbach’s α) 
 
 
Interrater reliability 
(ICC) 
 
  
N=47‡ 
 
N=28† 
Social communication and interaction 
(‘scale A’) 
 
0.95 
 
0.96* 
 
 
Social emotional reciprocity (subscale A1) 
 
 
0.83 
 
0.93* 
 
Deficits in non-verbal behaviour used for 
social interaction (subscale A2) 
 
 
0.91 
 
0.98* 
Deficits in forming, maintaining and 
understanding relationships (subscale A3) 
 
 
0.88 
 
0.89* 
 
 
Repetitive interests (‘scale B’) 
 
 
0.92 
 
0.98* 
 
 
Stereotyped repetitive movements or 
speech (subscale B1) 
 
0.67 
 
0.97* 
 
Insistence on sameness (subscale B2) 
 
 
0.87 
 
0.94* 
 
 
Restricted fixated interests (subscale B3)        
 
 
0.62 
 
0.92* 
 
 
Abnormal sensory response (subscale B4) 
 
0.69 
 
0.93* 
Note:  ‡  Due to missing data: N ranges from 31-45 for internal consistency analysis.  
†  A sample of 29 participant 3Di-sva interviews were assessed for interrater reliability.  Due 
to missing data N ranges from 27-28 for this analysis. 
* p < 0.001 
Interrater reliability 
Intraclass correlations for the 3Di-sva current algorithm were high, with each 
of the scales and subscales yielding ICCs in excess of 0.89 (Table 7). 
Criterion validity 
Mean scores obtained by the ASD group and the clinical comparison group 
on each 3Di-sva current algorithm scale and subscale are displayed in Table 8. 
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Table 8  
Differences in 3Di-sva current algorithm scores between groups (N=47) 
 
Scale / subscale of the 3Di-sva 
 
Range‡ 
 
ASD 
 
n=27† 
 
Clinical  
comparison 
group 
 
n=20 
 
Significance* 
 
Effect size 
Social communication and interaction (scale A) 
Mean (SD) 
Median 
 
0-6 
 
 
3.02 (0.93) 
3.10 
 
 
0.73 (1.05) 
0.29 
 
U = 39.00, z = -4.97, p < 0.001 
 
 
 
r = -0.72 
Social emotional reciprocity (A1) 
Mean (SD) 
Median 
0-2  
1.01 (0.32) 
1.10 
 
0.29 (0.48) 
0.00 
 
 
U = 59.50, z = -4.57, p < 0.001
 
 
r = -0.67 
Deficits in non-verbal behaviour used for social 
interaction (A2) 
Mean (SD) 
Median 
 
0-2  
 
0.92 (0.41) 
0.80 
 
 
0.18 (0.28) 
0.00 
 
 
 
U = 36.00, z = -5.07, p < 0.001 
 
 
r = -0.74 
Deficits in forming, maintaining and 
understanding relationships (A3) 
Mean (SD) 
Median 
 
0-2  
 
1.08 (0.43) 
1.11 
 
 
 
0.27 (0.34) 
0.11 
 
 
 
U = 52.00, z = -4.71, p < 0.001 
 
 
r = -0.69 
Repetitive interests (scale B) 
Mean (SD) 
Median 
0-8  
4.17 (2.05) 
4.17 
 
 
0.69 (0.83) 
0.33 
 
U = 31.50, z = -5.14, p < 0.001 
 
r = -0.75 
Stereotyped repetitive movements or speech (B1) 
Mean (SD) 
Median 
0-2  
0.91 (0.63) 
1.00 
 
 
 
0.08 (0.24) 
0.00 
 
U = 60.00, z = -4.67, p < 0.001 
 
r = -0.69 
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Scale / subscale of the 3Di-sva 
 
Range‡ 
 
ASD 
 
n=27† 
 
Clinical  
comparison 
group 
 
n=20 
 
Significance* 
 
Effect size 
Insistence on sameness (B2) 
Mean (SD) 
Median 
0-2  
1.51 (0.68) 
2.00 
 
 
0.26 (0.42) 
0.00 
 
U = 51.50, z = -4.87, p < 0.001 
 
r = -0.71 
Restricted fixated interests (B3) 
Mean (SD) 
Median 
 
0-2  
1.07 (0.67) 
1.00 
 
0.17 (0.28) 
0.00 
 
U = 59.50, z = -4.66, p < 0.001 
 
r = -0.68 
Abnormal sensory response (B4) 
Mean (SD) 
Median 
 
0-2  
0.74 (0.62) 
0.71 
 
0.18 (0.26) 
0.00 
 
U = 123.50, z = -3.15, p = 0.002 
 
r = -0.46 
‡ Higher score signifies greater impairment 
† Due to missing data, n ranges from 26-27   
* Asymptotic significance values are displayed
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Mann Whitney U tests show that the ASD group scored significantly higher than the 
clinical comparison group on all nine of the scales.  Effect sizes for both A and B 
scales are above the .5 threshold for a large effect (Field, 2005), and effect sizes for 
the subscales all fall within the medium to high range.  Population pyramid charts for 
3Di-sva current algorithm scores on the A and B scales are displayed in Figures 7 
and 8 respectively.  
 
Figure 7.  Distribution of ASD and clinical comparison group scores on the A 
scale of the 3Di-sva current algorithm 
 
Figure 8. Distribution of ASD and clinical comparison group scores on the B 
scale of the 3Di-sva current algorithm 
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ROC analysis  
The 3Di-sva current algorithm was able accurately to discriminate between 
ASD cases and clinical comparison cases on both the A and B scales, with areas 
under the curve exceeding 0.93 (Figure 9). The A scale was found to have AUC = 
.93 (SE=.05), p<.001, 95% CI [.84, 1.0] and the B scale, AUC = .94 (SE=.03), 
p<.001, 95% CI [.88, 1.0]. 
Optimal cut-offs for the 3Di-sva current algorithm, selected to maximise 
sensitivity and specificity of the measure, were as follows: a scaled score of 1.5 on 
the A scale (range 0-6) and a scaled score of 1.9 on the B scale (range 0-8).  As with 
the 3Di-sva full algorithm, an individual must meet the scoring cut-off on both scales 
in order to qualify for a diagnosis of ASD according to the 3Di-sva current 
algorithm.   
 
Figure 9.  ROC curve of the 3Di-sva current algorithm A scale (AUC= .93) and B 
scale (AUC=.94) 
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The proportion of cases correctly identified by the 3Di-sva current algorithm 
as having ASD is displayed in Table 9. 
Table 9  
Participant diagnoses identified by the 3Di-sva current algorithm 
 
Participant  
Group 
 
 
3Di-sva diagnosis 
 
  
ASD 
 
Non-ASD 
 
 
ASD  
 
23 4 
 
Clinical 
Comparison 
 
1 19 
 
Using these figures, sensitivity of the 3Di-sva current algorithm was 
calculated at 0.85 (95% CI [.66, .96]) and specificity at 0.95 (95% CI [.75, 1]).  The 
positive predictive value of the 3Di-sva current algorithm was found to be 0.96 (95% 
CI [.79, 1]) and the negative predictive value was 0.83 (95% CI [.61, .95]).  
Discussion 
 Standardised instruments are needed to facilitate the challenging process of 
diagnosing ASD in adults.  Whereas great improvements have been made over the 
past 30 years in the identification of ASD in children, research into the assessment 
process in adults has been somewhat neglected (Bastiaansen et al., 2011; NICE, 
2012).  In particular, adult-specific informant report measures are an important 
component of a comprehensive assessment process which collects data from multiple 
sources.  This study examined the psychometric properties of a new informant report 
measure, the 3Di-sva, in a sample of adults with an established ASD diagnosis and a 
clinical comparison group of individuals with mental health difficulties and no 
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history of ASD.  The psychometric properties of an abbreviated version of the 3Di-
sva algorithm (focusing exclusively on the current functioning of the individual) 
were also examined.  
 3Di-sva full algorithm 
 This study found the full length 3Di-sva to be a reliable measure.  The tool 
demonstrated good interrater reliability when scored by an individual who was blind 
as to participant group, suggesting the 3Di-sva full algorithm can generate consistent 
agreement among interviewers.  In addition, each of the scales and subscales of the 
full length 3Di-sva (excluding subscale B1) was found to have acceptable to 
excellent internal consistency, suggesting the questions in each scale measure the 
same underlying construct.  Subscale B1 (stereotyped or repetitive movements) fell 
just short of the minimum recommended Cronbach’s alpha coefficient of 0.7 (Kline, 
2000).  However, it is worth noting that this subscale consists of just three items and 
studies have shown that the number of items in a scale may have a significant impact 
on Cronbach’s alpha, with longer scales tending to have higher values of alpha (e.g. 
Cortina, 1993).   Indeed, all the subscales of the B scale have significantly fewer 
items than those of the A scale and this may have contributed to the slightly lower 
internal consistency found for the B subscales.  It would be useful to assess whether 
the addition of further items testing the same underlying concept would improve the 
internal consistency of the subscales of the B scale without introducing redundant 
questions.   
The inclusion of additional items on the B scale would also help to redress 
the balance of the interview, which currently asks a great many more questions 
related to the domain of social communication and interaction than to that of 
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restricted, repetitive patterns of behaviour.  The scoring algorithm tackles this 
imbalance by adjusting subscale scores to ensure that each subscale carries equal 
weight.  However, arguably it would improve the content validity of the measure if 
the A and B scales were more balanced in terms of volume of items, thereby more 
accurately reflecting DSM-5.  Notably, other measures used in the assessment of 
ASD also reflect this imbalance.  For example, the ADI-R (Lord et al., 1994) has 29 
items to measure social communication issues and only eight items to measure 
restricted, repetitive behaviours.  This suggests there is a general need for further 
research into the measurement of restricted, repetitive behaviours and interests in 
ASD.   
The full length 3Di-sva was found to have good general criterion validity as 
demonstrated by the difference in scores obtained by participants with an established 
ASD diagnosis compared to those obtained by clinical comparison participants.  
ASD participants scored significantly higher than clinical comparison participants on 
all scales and subscales of the measure and large effect sizes were found.  The 
measure was able accurately to distinguish between ASD cases and clinical 
comparison cases as demonstrated by the high Areas under the Curve for each of the 
A and B scales.  Sensitivity (0.85) and specificity (0.90) of the measure suggest it is 
capable of correctly distinguishing between positive cases of ASD and clinical 
comparison (i.e. non-ASD) cases the majority of the time.  Given the potential 
overlap in symptomatology between ASD and the mental health difficulties 
experienced by participants in the clinical comparison group, the task set for the 3Di-
sva in this study was a reasonably challenging one, comparable to the task facing 
clinicians working in adult mental health services.  Nevertheless, the majority of 
participants in the clinical comparison group were not suspected of having ASD at 
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the time of assessment.  A more ecologically valid, task in terms of assessing the 
validity of the 3Di-sva as a diagnostic tool, would be to assess its ability to 
discriminate between adults, all of whom were suspected of having ASD but some of 
whom were established as having other mental health difficulties underlying their 
symptomatology.   
The 3Di-sva full algorithm failed to identify four individuals with ASD.  For 
the purposes of assessing sensitivity and specificity, consistent with DSM-5 
diagnostic criteria, an individual was only classified as positive for ASD if he or she 
reached the appropriate threshold on each of the A (social communication and 
interaction) and B (restricted repetitive behaviour, interests or activities) scales, 
representing the two core domains of ASD symptomatology.   Two of these four 
false negative cases narrowly missed the threshold on the A scale but reached the 
threshold on the B scale.  One case missed the threshold on both scales and one case 
missed only the B scale cut-off.  These findings highlight the challenge involved in 
diagnosing complex cases of ASD and the need for multiple components in a 
comprehensive assessment process, including direct observation of an individual’s 
behaviour wherever possible (NICE, 2012).   
The full length 3Di-sva incorrectly identified two clinical comparison cases 
(scoring above the cut-off point on both A and B scales) as having ASD.  Both these 
individuals were assessed for ASD by one of the specialist ASD clinics participating 
in this study but were given differential diagnoses after ASD had been ruled out.  
One was diagnosed with depression, the other with social anxiety disorder.  It is 
perhaps not surprising that individuals who present with so many symptoms 
consistent with ASD that they are referred to a specialist ASD clinic for assessment 
should prove particularly challenging for the measure to identify correctly.   Caron 
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and Rutter (1991) highlight the fact that certain behaviours may represent non-
specific indicators of psychopathology generally, with increased severity of a 
disorder often being associated with an increase in the number of such non-specific 
indicators.  Both depression and social anxiety disorder are associated with forms of 
behaviour which also appear in the diagnostic criteria for ASD (DSM-5; APA, 
2013a).  Symptoms of depression which are also characteristic of ASD include social 
withdrawal, flattened affect, limited facial expression and a decrease in the volume, 
amount and inflexion of speech (e.g. DSM-5; APA, 2013a; Hofvander et al., 2009).  
ASD is listed as a differential diagnosis for social anxiety disorder in DSM-5 and it is 
acknowledged that key features of social anxiety disorder (social communication 
difficulties and fear of social situations) are also characteristic of ASD (APA, 
2013a).  Again, this finding highlights the need, in clinical practice, for a broad 
assessment process involving a multidisciplinary team of clinicians who are able to 
debate complex presentations and reach clinical consensus as to whether a diagnosis 
is appropriate or helpful (NICE, 2012).    
This study found the full length 3Di-sva to be relatively quick to administer 
with interviews taking between 15 and 75 minutes to conduct.  Training in the use of 
the 3Di-sva appeared to be swift and efficient with each researcher or clinician 
receiving around an hour of guidance prior to first administration of the measure.  
Importantly, brief training in respect of how to score the 3Di-sva appeared to be 
satisfactory for the less experienced psychology undergraduate who assisted the 
researchers by scoring recordings of the interviews for the assessment of interrater 
reliability.  Notably, interviews were carried out successfully both in person and over 
the telephone, suggesting the tool may have particular utility in clinical practice 
where informants are not always able to attend in person.   
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3Di-sva current algorithm 
This study also examined the psychometric properties of the 3Di-sva current 
algorithm, an abbreviated version of the 3Di-sva algorithm which only includes 
questions about the current functioning of the individual.  Whilst DSM-5 criteria 
state that symptoms of ASD must have been present in early childhood, in clinical 
practice it is not always possible to involve a family member, or other informant who 
has known the adult well since childhood, in the assessment process.  As such, it was 
felt to be pragmatic to assess the psychometric properties of this abbreviated version 
of the scoring algorithm suitable for use with an informant who can only speak as to 
the individual’s current functioning.     
The 3Di-sva current algorithm was also found to be a reliable measure.  
Interrater reliability was good.  The A and B scales were found to have excellent 
internal consistency, as were all three A subscales and subscale B2.  Subscales B1, 
B3 and B4 fell below the recommended Cronbach’s alpha coefficient of 0.7 (Kline, 
2000).  Again, the very small number of items in these scales, further reduced by 
removal of questions relating to early development, may have impacted on the value 
of Cronbach’s alpha (Cortina, 1993).     
The 3Di-sva current algorithm demonstrated good general criterion validity.  
As with the full algorithm, ASD participants scored significantly higher than clinical 
comparison participants on all scales and subscales of the measure, with large effect 
sizes on the A and B scales and medium to large effect sizes on all subscales.  High 
Areas under the Curve for each of the A and B scales demonstrated the current 
algorithm’s ability accurately to distinguish between ASD cases and clinical 
comparison cases.  Sensitivity (0.85) and specificity (0.95) of the current algorithm 
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suggest it is capable of correctly distinguishing between positive cases of ASD and 
non-ASD cases the majority of the time.  The clinical comparison group in this study 
included two younger sibling informants who were unable to answer 3Di-sva 
questions regarding the individual’s childhood, however the vast majority of data 
were collected from informants (such as parents) who had known the individual well 
as a child.  In future research it would be important to assess the psychometric 
properties of the 3Di-sva current algorithm when employed solely with informants 
who did not know the individual in childhood, for example, friends or non-familial 
carers.  
The 3Di-sva current algorithm failed to identify four individuals with ASD.  
All of these misdiagnosed cases reached the cut-off for the A scale and missed the 
threshold on the B scale.  Research suggests there exists a group of individuals who 
have significant social communication and interaction difficulties but fail to manifest 
restricted, repetitive patterns of behaviour or interests to a clinical degree (e.g. 
Mandy & Skuse, 2008; Walker et al., 2004).  DSM-5 created a new diagnosis of 
Social Communication Disorder to capture such cases but also states that full ASD 
diagnostic criteria may be met by an adult where such restricted, repetitive interests 
were manifest in childhood even if they are not present at the time of assessment 
(APA, 2013a).  This raises the possibility that the 3Di-sva current algorithm, 
focusing as it does exclusively on current presentation in adults, may be missing 
individuals who no longer display clinically significant levels of restricted, repetitive 
behaviour symptoms.  Whilst there is evidence of a modest degree of improvement 
in ASD symptoms, including those related to restricted and repetitive behaviours, in 
adolescence and adulthood (e.g. Seltzer, Shattuck, Abbeduto & Greenberg, 2004), 
studies suggest that the improvement may in fact be more limited in this domain than 
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in the area of social communication (e.g. Taylor & Seltzer, 2010).  In the present 
study, two of the misdiagnosed participants were also incorrectly excluded by the full 
algorithm, suggesting these may have been particularly subtle ASD presentations 
requiring additional means of assessment. The remaining misdiagnosed participants 
may have manifested more severe restricted, repetitive behaviours in childhood, 
emphasising that access to information about an individual’s past history remains 
important.  Where there is no available informant in possession of such historical 
information, documentary evidence, such as school reports, may be sought (NICE, 
2012).  A further possibility is that restricted, repetitive behaviours may become 
more subtle as individuals age and that items in the 3Di-sva were not sophisticated 
enough to capture these subtleties.  Studies suggesting that restricted repetitive 
behaviours may become less frequent and less severe among older individuals 
nevertheless show that such behaviours do continue to manifest in older age 
(Esbensen, Seltzer, Lam & Bodfish, 2009).  Further research into the presentation of 
restricted, repetitive behaviours in adults with ASD as compared with typically 
developed adults would be valuable and may aid the development of interview 
questions particularly suited to an adult population.  
Limitations and future directions 
 The present study investigates the psychometric properties of the 3Di-sva in a 
sample of adults with an established ASD diagnosis and a comparison group of 
individuals with a range of different mental health difficulties.  Initially, the 
researchers sought two separate clinical comparison groups of (1) individuals with 
psychotic disorders and (2) individuals with depression and anxiety disorders, to 
allow for separate statistical analyses.  However, as it was not possible to recruit 
separate samples of sufficient size, these groups were collapsed into one comparison 
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group and recruitment was extended to include a broader range of mental health 
diagnoses, including personality disorders.  In clinical practice, it is important to rule 
out potential differential diagnoses that can give rise to similar symptoms to ASD.  A 
limitation of the present study is that very few participants in the clinical comparison 
group were genuinely suspected of having ASD at the time of assessment.  Such a 
clinical comparison group would have provided a more ecologically valid task for 
the 3Di-sva, in terms of posing a particular challenge for the tool in accurately 
identifying true cases of ASD.  An important direction for future research would 
involve testing the psychometric properties of the 3Di-sva in the context of a group 
of individuals all of whom have symptoms consistent with ASD but only some of 
whom are diagnosed with the condition.  Future research could also address the 
heterogeneity of the comparison group here by recruiting groups with specific 
separate clinical diagnoses and comparing the psychometric properties of the 3Di-sva 
in these groups.  This would provide valuable information as to the ability of the 
3Di-sva to differentiate between individuals with ASD and individuals with specific 
mental health disorders, rather than mental health difficulties in general.  For 
example, adult participants experiencing negative symptoms associated with 
schizophrenia have been found to be particularly difficult to distinguish from 
individuals with ASD when administering the ADOS module 4 (Bastiaansen et al., 
2011) and it would be interesting to investigate the 3Di-sva’s ability to differentiate 
between these particular populations.  
 It is also important to explore the psychometric properties of the 3Di-sva in a 
population of individuals who have never received a DSM diagnosis of 
neurodevelopmental or mental health difficulties.  As previously mentioned, this 
research has been carried out in a concurrent study (Clarke, 2015).   
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In deciding whether or not to provide a diagnosis of ASD, the clinical teams 
at the ASD clinics participating in this study did take into consideration information 
collected during the 3Di-sva interview process, such information forming part of all 
data available to the team relating to an individual being assessed.  It could be argued 
that such consideration constitutes a limitation in this study because it creates the risk 
of circularity.  However, this risk was mitigated by imposing an inclusion criterion 
that all participants in the ASD group must meet criteria for ASD as assessed 
specifically by the ADOS and by the fact that the 3Di-sva scoring algorithm was not 
utilised at all in the diagnostic decision-making process. It would be beneficial, in 
future studies, to make use of the ADI-R, both as a means of obtaining collateral 
information about the individual as part of the assessment process (rather than the 
3Di-sva) and as a means of further investigating the criterion validity of the 3Di-sva 
by comparing results with those of an alternative ‘gold standard’ informant report 
measure. 
Clarke (2015) investigated the correlation between the 3Di-sva and the 
ADOS module 4, however the relatively small sample size in that study may have 
limited the findings and further exploration is warranted.  Construct validity of the 
3Di-sva could be tested in future research using factor analysis.   
 A further limitation of this study was the failure to assess test retest 
reliability, due to limited time and resources.  It will be important in the future to 
evaluate the stability of 3Di-sva diagnoses across time by re-assessing individuals 
after an appropriate period has elapsed.    
 The participants in the clinical comparison group in this study (excluding the 
four participants initially assessed by a specialist ASD clinic) were not assessed for 
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ASD by means of a measure validated for use with adults (such as, the ADI-R, the 
ADOS module 4, or the RAADS).  Again this was due to limited resources in the 
present study.   Future research could address this potential confounding factor by 
inviting comparison participants to engage in a comprehensive ASD assessment and 
offering greater incentives to compensate for the time and inconvenience involved in 
such a process. 
 The sample size in this study is relatively small and it would be valuable for 
future research to expand on the number of participants included here.  For example, 
the size of the sample may have had an impact on the accuracy of the sensitivity and 
specificity values reported here.  In addition, it was not possible to evaluate the 
internal consistency of the 3Di-sva scales and subscales for each individual group of 
participants; values reported here are for the entire sample.  This was due to there 
being insufficient variance within the groups (in particular, within the comparison 
group) on certain subscales, whereas a larger sample may have contributed to greater 
variance.  Nevertheless the number of participants here is similar to that of samples 
studied in research examining the psychometric properties of other diagnostic tools 
(e.g. ADI-R; Lord et al., 1994) and the size was sufficient for the purpose of 
detecting the substantial differences between groups found here with large effect 
sizes.   A relatively small proportion (n=10) of the ASD group interviews were 
recorded for the purposes of assessing interrater reliability.  Future research would 
benefit from inclusion of greater numbers of participants in the interrater reliability 
assessment.  
 Interviews in this study were administered both in person and over the 
telephone, however no analysis was conducted investigating any difference in 
outcome according to means of administration.  Such analysis would have been 
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difficult to carry out in this research due to the small proportion of interviews carried 
out in person in the clinical comparison group (n=3) and, conversely, the small 
proportion of interviews known to have been carried out over the telephone in the 
ASD group (n=5).   A further potential confound that would be useful to investigate 
in future research is the identity of the informant being interviewed.  In the present 
study all known informants in the ASD group were mothers, as were the majority of 
informants in the comparison group (n=14), meaning that there were insufficient 
numbers of non-maternal informants to allow for meaningful comparison of 
outcome.  The 3Di was specifically designed to minimise respondent bias, with 
questions clustered according to areas of function rather than according to diagnostic 
criteria (Skuse et al., 2004).  It is also a highly structured measure which should 
lessen any effect of method of administration.   However, future research involving a 
larger sample size could usefully examine any impact of such factors.  
Finally, given that intellectual disability has been specifically identified as a 
differential diagnosis to be considered when assessing an individual for ASD (NICE, 
2011) and is a potential coexisting condition with some 25% of individuals with 
ASD also diagnosed as having an IQ below the normal range (Medical Research 
Council, 2001), it would be important for future studies to assess the psychometric 
properties of the 3Di-sva in an intellectual disability population. 
Conclusions and implications 
In summary, this study provides promising evidence to suggest that the 3Di-
sva is a well validated, reliable informant report instrument for the diagnosis of 
autism spectrum disorders in adults.  It has been shown adequately to discriminate 
ASD from other mental health difficulties in an adult population, although it is 
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important to acknowledge that only a very small proportion of participants in the 
clinical comparison group were suspected of having ASD at the time of assessment.  
Given the association between ASD and a range of other disorders, such as 
depression and anxiety, and the overlap in symptomatology of ASD and other 
conditions, it is vital that assessment tools be capable of disentangling ASD 
symptoms from other factors in a complex clinical presentation.  It will be very 
important in future research to assess the psychometric properties of the 3Di-sva in a 
sample of individuals, all of whom have symptoms consistent with ASD.  Such 
research will need to ensure that the tool is capable of distinguishing true cases of 
ASD from cases where ASD-like symptoms are better explained by other mental 
health difficulties.  
The 3Di-sva is one of the first tools to be structured specifically according to 
DSM-5 criteria, assessing the full range of symptoms described and providing a valid 
DSM-5 diagnosis (APA, 2013a).  It is also simple to use, requiring only an hour of 
training prior to first administration.  It is time efficient relative to other informant 
report measures, enhancing its utility in resource-strapped clinical settings.  
This research, in conjunction with Clarke (2015), constitutes an important 
first step in establishing the validity and reliability of this new informant report 
measure for use with adults.  Given the paucity of psychometric evidence for use in 
adult populations reported by NICE (2012) for existing informant report measures, 
the ADI-R, AAA, ASDI and DISCO, there is a need for novel tools which are valid 
and reliable.  It is hoped that the 3Di-sva may constitute a useful addition to the 
battery of measures required to carry out a ‘gold standard’ comprehensive 
assessment of adults with complex presentations, alongside observational tools, such 
as the ADOS, and self-report tools, such as the RAADS.  
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Future research is needed to provide further evidence of the psychometric 
properties of the 3Di-sva, including test-retest reliability, criterion validity and 
studies benefitting from larger sample sizes in which all individuals were suspected 
of having ASD at the time of assessment.  However, this research represents a 
promising foundation upon which to base further research into the utility of this 
measure.  
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Introduction 
This critical appraisal provides additional reflection on aspects of the research 
process which have been particularly thought-provoking.  It begins with a reflection 
on elements of my personal clinical experience working with individuals with autism 
spectrum and other mental health disorders, and of the challenge involved in 
untangling complex presentations in the clinic.  It goes on to consider the ways in 
which such experiences contributed to the literature review and the research project, 
as well as the evolution of my personal perspective on both research and clinical 
practice through the research process.  Some of the methodological challenges 
encountered throughout this process will also be considered.   
Clinical experiences of autism spectrum disorder and psychosis 
My experiences as a trainee clinical psychologist working across psychosis 
services in an NHS mental health trust first drew my attention to the possibility of an 
overlap or association between autism spectrum disorder (ASD) and psychosis.  I 
became aware of a proportion of individuals receiving treatment for psychosis in 
adult psychiatric services who were also observed to present with features 
resembling ASD.  As a clinician, I considered a number of possible factors that 
might explain this.   
Certain symptoms of psychosis (possibly exacerbated by side effects 
associated with anti-psychotic medication) might be mistaken for ASD, for example, 
social withdrawal, impaired reciprocal social interaction, monotonous tone of voice, 
unusual or reduced eye contact and gesture, minimal response to other people’s facial 
expressions and a tendency to miss social cues.  Alternatively, unrecognised 
symptoms of ASD may have been misconstrued as psychosis, potentially leading to a 
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stigmatising diagnosis and the inappropriate administration of powerful anti-
psychotic medication associated with significant side effects and risks to health.   
My experiences of working on a child psychiatric inpatient unit further 
highlighted the risk of misattribution of features of ASD to a psychotic disorder in a 
child population.  A number of children were referred to the unit with a diagnosis of 
ASD and additional concerns around the possibility of psychotic symptoms.  
Detailed observation of these children was carried out in a range of contexts to try to 
assess whether their behaviour was suggestive of psychosis.  In the vast majority of 
cases, whilst there was behaviour that might have been considered ‘unusual’, the 
clinical consensus was that it could be explained by ASD alone.  Children may have 
appeared preoccupied without obvious reason, seemed particularly caught up in an 
imaginary world, shown unusual gaze patterns, or mumbled to themselves, but there 
was often no clear evidence of psychosis.  Rather they appeared to be focused on 
stereotypic preoccupations, hyper or hypo sensitive to sensory stimuli (e.g. gazing 
intently at a speck of dust caught in a beam of sunlight), avoidant of, and 
uncomfortable with, all aspects of social interaction on the unit, or anxious in general 
(e.g. Dossetor, 2007).  
A further possibility was that adults with undiagnosed ASD might be 
presenting in psychiatric services with co-occurring psychotic symptoms.  If so, 
could this be explained in terms of ASD and psychosis sharing the same aetiological 
underpinnings, or did ASD convey a particular risk of developing psychotic 
symptoms?  Moreover, might the failure to diagnose this neurodevelopmental 
disorder in childhood itself have contributed to these individuals experiencing 
hardship, misunderstanding, loss of opportunity and increased vulnerability to 
comorbid mental health difficulties? 
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From personal experience to systematic literature review 
These personal clinical experiences highlighted the importance of gaining a 
detailed understanding of the relationship between ASD and psychosis in order to 
enhance evidence based approaches to assessing and supporting individuals with 
complex presentations in the clinic.  An investigation into existing literature 
estimating rates of co-occurrence of the two disorders seemed a logical next step.  
I was immediately struck by the wide variability in methodology of studies 
investigating the co-occurrence of these disorders and the considerable risk of bias 
associated with many current estimates.  Moreover, whilst my search terms identified 
a significant number of studies for screening by hand, as I progressed with this 
process it became apparent that some studies may have inadvertently been excluded 
from the review due to the broader term ‘psychopathology’ being used by 
researchers to describe the subject of their research.  This reflected a tendency for 
many studies reviewed not to be investigating co-occurrence of ASD and psychosis 
as a primary research question which issue, in itself, could be argued to carry a risk 
of bias.   
My original personal experience of the questions around co-occurrence was 
in the context of a psychosis population.  However, in carrying out this review, it was 
notable that research into the prevalence of ASD in individuals with psychosis 
appeared to be particularly unreliable due to a range of methodological and 
nosological problems.  Whilst I felt able to draw tentative conclusions as to the likely 
prevalence of psychosis in an ASD population, I struggled to reach any solid 
conclusions for the prevalence of ASD among individuals with psychosis.   
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Studies varied as to the included or excluded autism spectrum diagnoses as 
set out, for example, in DSM-IV.  Future studies would benefit from applying a 
comprehensive ‘autism spectrum disorder’ criterion for case ascertainment, as now 
set out in DSM-5.  Many studies utilised non-validated screening tools, or screened 
by means of an initial record review, prior to carrying out any detailed assessment for 
ASD, acknowledging that there were simply not the resources to carry out the 
lengthy process involved in such assessments with every participant in the sample.  
Even then, most studies failed to use an assessment tool recommended for use with 
adults by NICE guidelines.  This struck me as contrasting with the formal diagnostic 
procedures for ASD utilised in a specialist adult ASD service (such as the clinics 
where we had recruited our ASD group for the major research project).  A further 
practical difficulty posed by this particular population is that individuals with 
psychosis may be too acutely unwell to assess directly by means of an observation 
measure such as the ADOS, but it seemed that many individuals participating in the 
included studies did not have a close relative available to complete an informant 
report measure of functioning since early childhood.  This latter issue proved only 
too pertinent to my own empirical research. 
The range of estimates of prevalence of psychosis in an ASD population was 
even broader than that of ASD in individuals with psychosis (0% to 61.5% as 
opposed to 0.8% to 27%).  However, the process of unpicking sources of potential 
bias, so as to allow for meaningful comparison of figures, seemed a little less 
challenging.  Methods employed in the ascertainment of ASD cases appeared to be 
more reliable (although, again, a minority stipulated use of a NICE-recommended 
tool).  In ascertaining cases of psychosis, some of the studies utilised a range of 
methods commonly seen in the clinic, including direct clinical interview, symptom 
132 
checklists, informant collateral interview and some structured diagnostic tools.  
However, of underlying significance seemed to be the fact that the identification of 
psychosis in individuals with ASD can be difficult (for all the reasons outlined in the 
review) and that there are no tools designed specifically for this task.   
The literature review highlighted the practical barriers to carrying out 
meticulous population-based studies investigating this issue.  Future investigations of 
rates of co-occurrence of ASD and psychosis might involve large scale longitudinal 
studies aiming routinely to invite all individuals diagnosed with ASD for follow-up 
as they progress into adulthood, including a comprehensive mental health 
assessment.   
From personal experience to empirical research 
The clinical experiences of adult psychiatric services recounted above drew 
my attention to the limited service provision for individuals presenting in adult 
services with suspected ASD.  In the context of general adult mental health services 
there seemed to be a lack of expertise or resource available to carry out the 
appropriate ASD assessments.  In particular, measures constituting the ‘gold 
standard’ in assessing ASD in adults, such as the Autism Diagnostic Observation 
Schedule (ADOS; Lord et al., 2000) and the Autism Diagnostic Interview-Revised 
(ADI-R; Lord, Rutter & Le Couteur, 1994), required specialist and costly training 
unavailable to clinicians working in general adult services.  Not only was there a lack 
of ready access to such measures in adult mental health services but assessment by 
specialist adult ASD services was subject to long waiting lists.  I was aware that the 
UK government had published statutory guidance (Department of Health, 2010) 
setting out recommendations for a clear and consistent pathway to diagnosis of ASD 
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in adults.  However, with increased financial pressure on the National Health Service 
in the face of an effective budget freeze and cuts to social care services over recent 
years (The King’s Fund, 2015), it seemed that in practice there was some way to go 
before such plans would be properly implemented.   
It was against this backdrop that the need for additional efficient and effective 
tools for the assessment of ASD in adults presented itself to me.  I embarked upon 
the research project convinced of the clinical relevance and importance of the study.  
Having seen the deficiencies for myself, and specifically in the context of more 
generalised adult mental health services, I was, perhaps naively, convinced that the 
pressing purpose of the research would be easily conveyed to services and potential 
participants alike.  
The challenges involved in recruiting a clinical comparison group 
Whilst I anticipated that it would be challenging to recruit individuals with 
mental health difficulties – and their parents – to our study, the full extent of the 
challenge that confronted us took me by surprise.  My fellow joint project researcher 
and I had originally planned to recruit two separate clinical comparison groups, (i) 
psychotic disorders and (ii) affective disorders, to allow for separate, disorder-
specific, statistical analyses.  However, it soon became apparent that the recruitment 
of two groups of sufficient size would prove impossible in the time available to us.  
Firstly, we were we trying to persuade individuals with mental health difficulties 
other than ASD to participate in a project researching a neurodevelopmental disorder 
with which they had no personal connection.  Secondly, we were trying to persuade 
these individuals to invite a parent or other relative to answer detailed and potentially 
intrusive questions about them – relating to their childhood and current presentation.  
Finally, assuming we could persuade the individual to agree to their relative being 
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approached in this way, we needed to persuade this relative to give up the time 
needed for the interview to take place (albeit this could be over the telephone).  This 
proved to be a Herculean task.   
It proved particularly difficult to recruit individuals to the psychosis 
comparison group.  I had been warned prior to commencing the project that this 
group of individuals was potentially very difficult to recruit.  In particular, clinical 
experience suggested that a significant proportion of these individuals may not be on 
good terms with parents or other family members capable of completing the full 3Di-
sva interview, including questions on early childhood.  However, working closely 
with the pathway lead for inpatient and acute psychology in the NHS Trust where I 
was recruiting, we devised numerous strategies that we thought would encourage 
participation.  This included close liaison with a number of teams across the Trust, 
many hours spent sitting in clinic waiting rooms chatting to individuals passing 
through and an offer to run brief psychoeducation workshops for carers of 
individuals with psychosis, in the hope of recruiting family members and winning 
favour with stretched NHS teams.  We also increased the compensation paid to 
individuals and their relatives from a £5 to a £10 voucher each, in the hope of 
speeding up recruitment.  Whilst this did help, it was insufficient to encourage the 
participants needed to make up two separate clinical comparison groups.  We were 
forced to collapse the two groups into one broad clinical comparison group and 
extend recruitment to include a broader range of mental health diagnoses, including 
personality disorders.   
Studies investigating the issues which influence recruitment to mental health 
research have highlighted factors taken into consideration by individuals deciding 
whether to participate, and by health care professionals deciding whether to 
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recommend a study to their patients.  A key factor in this decision making process is 
an assessment of whether involvement in the study will be beneficial to the 
individual concerned, for example, whether the project will add to the care being 
provided to the individual (e.g. Bucci, Butcher, Hartley, Neil, Mulligan & Haddock, 
2015; Hughes-Morley, Young, Waheed, Small & Bower, 2015).  Our study could not 
be argued to add to, or facilitate, the care of individuals in the clinical comparison 
group with mental health needs.  The development and validation of an effective, 
user-friendly tool for the assessment of ASD in a clinical population may prove to be 
a valuable asset in the care of individuals presenting to services with complex 
presentations and uncertainty as to symptoms of ASD or mental health difficulties or 
both.  However, such individuals were excluded from the present study unless 
concerns as to ASD had been specifically ruled out by clinical consensus at the ASD 
clinic.  In their systematic review of qualitative studies investigating factors affecting 
recruitment into depression trials, Hughes-Morley and colleagues (2015) did identify 
a sub-theme of ‘altruism’ as a factor reported to impact patients’ decision as to 
whether to enrol in trials. Whilst it was found that patients did want to help others 
and contribute to the body of research, they were far more likely to participate if they 
also felt that they were helping themselves in the process (Hughes-Morley et al., 
2015).  In the present study, we were asking potential participants to enrol in a study 
that would be of no direct benefit to them and to contribute to knowledge around a 
field that had little or nothing to do with their own difficulties.   
Another barrier to participation identified by the literature is, understandably, 
the question of how acutely unwell or distressed the individual is, or is perceived to 
be by a ‘gate-keeping’ clinician (Bucci et al., 2015; Hughes-Morley et al., 2015).  
This may be a particular issue when dealing with a psychosis population attending 
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secondary care services, with individuals potentially facing ongoing challenging 
mental health symptoms, unpleasant side effects of medication, social isolation and 
significant adversity.   
The experience of attempting to recruit individuals with psychosis (and other 
mental health difficulties) to this study left me wondering by what means such 
barriers to recruitment might be overcome, in order to progress important research.  
We did not have the opportunity, in the present study, to involve service users in the 
design of the research, or to consult with them as to methods of recruitment.  Future 
research might explore the views of service users with diagnoses of ASD or 
psychosis, or both.  I also reflected on the ideal of the scientist-practitioner model in 
the reality of a stretched National Health Service.  It seemed to me that, in an ideal 
world, clinical psychologists working in adult mental health services would be the 
very individuals researching tools such as the 3Di-sva and (subject to appropriate 
ethics) incorporating research assessments more seamlessly into their clinical 
practice.  However, I was aware that, with resources so scarce in mental health 
services, this was perhaps unrealistic.   
Methodological impact of recruitment difficulties 
 The recruitment difficulties referred to above inevitably had an impact on the 
sample of clinical comparison participants in this study.  On the one hand, our 
clinical comparison group was heterogenous.  Individuals were diagnosed with a 
broad range of mental health difficulties and it was not possible to investigate the 
ability of the 3Di-sva to distinguish between ASD and particular symptoms 
associated with a specific diagnosis.  As such, any potential variations in the validity 
of the 3Di-sva depending on the specific clinical population being assessed could not 
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be identified.  On the other hand, the participants in this group could be argued to be 
somewhat homogenous.  For example, they were likely to be the ‘less unwell’ 
individuals in a clinical population and were all in sufficiently close contact with 
family members to trust them to engage in a detailed, personal interview.   
Clinicians working in mental health services may, of course, work with 
individuals presenting with a broad range of difficulties, and in this sense it is argued 
that we have set the 3Di-sva an ecologically valid task in the present study.  
Nevertheless, in potentially failing to recruit those individuals with more severe, 
complex presentations, experiencing social isolation and ruptured family relations, 
we may have excluded precisely those individuals posing the greatest challenge to 
clinicians when it comes to distinguishing mental health difficulties from ASD.   
Increasing specificity of the 3Di-sva in an ASD clinic context? 
It was notable that, utilising the optimal cut-off points on both A and B 
scales, selected to maximise sensitivity and specificity of the measure based on the 
data in this project, the 3Di-sva failed to identify correctly as clinical comparison 
cases two participants who had previously been referred to the ASD assessment 
services with suspected ASD.  These individuals had been given differential 
diagnoses after a comprehensive assessment process had ruled out the possibility of 
ASD.  It is perhaps unsurprising, given this context, that the cut-off points selected in 
this study rendered the measure a little too sensitive for these individuals.  This led 
my fellow joint project researcher and I to reflect on the possibility of altering the 
cut-off points of the 3Di-sva depending on clinical setting and need.  For example, in 
an ASD clinic setting it might prove useful to increase the specificity of the measure, 
whereas in a general mental health setting sensitivity may be more of a priority, such 
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that individuals with suspected ASD might be flagged as needing a comprehensive 
assessment in a specialist service.  
Concluding remarks 
Whilst completing this thesis, I have learnt a huge amount about the process 
of carrying out both literature reviews and empirical research projects.  In reviewing 
the literature around co-occurrence of ASD and psychosis, I was able to explore 
existing research considering the very challenges I had experienced in clinical 
practice assessing adults with complex presentations.  This provided an invaluable 
context for the empirical research validating the use of an ASD assessment tool in a 
clinical setting, as well as highlighting some of the challenges I was to face in 
recruiting participants to my clinical comparison group.  The experience of 
completing the research project, notwithstanding the many obstacles in my path, and 
thereby contributing to the validation of this new, efficient measure for the 
assessment of ASD in adults, has reaffirmed for me the importance of persevering 
with such projects. Ultimately, I have a genuine sense that we have added value to 
the field of knowledge around ASD in adults and that we have taken steps to redress 
the imbalance in the breadth and quality of ASD assessment procedures available in 
adult services as compared to child.   
My personal experience of carrying out a joint research project has been 
extremely rewarding and I would recommend this to UCL trainee clinical 
psychologists considering this option.  The opportunity to share the burden of aspects 
of the project, such as obtaining NHS REC approval, preparing participant 
documentation, recruiting participants and deciding upon statistical analyses, has 
been invaluable.  In particular, having an ally with whom to share the challenges and 
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successes of this process at every turn was extremely beneficial to me and 
undoubtedly contributed to a richer experience over all.  
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Search terms 
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Medline Search Terms 
 Terms 
  
1 autis*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
 
2 asd.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
 
3 asperger*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
 
4 pervasive developmental disorder.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] 
 
5 pdd.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier] 
 
6 1 or 2 or 3 or 4 or 5 
 
7 child development disorders, pervasive/ or asperger syndrome/ or autistic disorder/ 
 
8 6 or 7 
 
9 psychosis.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
 
10 psychotic.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
 
11 schizophren*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
 
12 9 or 10 or 11 
 
13 psychotic disorders/ or schizophrenia/ or schizophrenia, catatonic/ or schizophrenia, 
disorganized/ or schizophrenia, paranoid/ or shared paranoid disorder/ 
 
14 12 or 13 
 
15 8 and 14 
 
16 limit 15 to (english language and humans) 
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PsychINFO Search Terms 
 Terms 
 
1 autis*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
 
2 asd.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests 
& measures] 
 
3 asperger*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
 
4 pervasive developmental disorder.mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
 
5 pdd.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests 
& measures] 
 
6 1 or 2 or 3 or 4 or 5 
 
7 pervasive developmental disorders/ or aspergers syndrome/ or autism/ 
 
8 6 or 7 
 
9 psychosis.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
 
10 psychotic.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
 
11 schizophren*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] 
 
12 9 or 10 or 11 
 
13 exp psychosis/ 
 
14 12 or 13 
 
15 8 and 14 
 
16 limit 15 to (human and english language) 
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APPENDIX C 
 
Researchers’ contributions to the joint project 
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This project was run jointly with Kiri Clarke.  Researcher contributions are set out 
below: 
Aspects of study completed jointly 
 All planning of study methodology.  
 Liaison with ASD services via which recruitment took place.  
 Writing the research project protocol.  
 Writing the NHS REC application.  
 Attending the NHS REC panel interview.  
Aspects of study completed by Michele McKenner 
 All liaison with mental health services other than IAPT via which recruitment 
of clinical comparison participants took place. 
 Writing of NHS R&D application relevant to mental health services other 
than IAPT 
 Writing of substantial amendment to NHS REC application relevant to 
recruitment of participants with psychosis 
 Recruitment and interviewing of clinical comparison participants other than 
those recruited via IAPT (n=8) and interviewing of one IAPT participant.  
 Recruitment of participants for the non-clinical control group (n=22). 
 Analysis and write-up of data for ASD group versus clinical comparison 
group.  
Aspects of study completed by Kiri Clarke 
 All liaison with IAPT services via which recruitment of clinical comparison 
participants took place. 
 Writing of NHS R&D applications relevant to the IAPT service and the ASD 
services. 
 Recruitment and interviewing of participants from the IAPT service for the 
clinical comparison group (n=8 recruited, n=7 interviewed). 
 Recruitment and interviewing participants from the ASD clinic (n=13).  
 Recruitment of participants for the non-clinical control group (n=5).  
 Analysis and write-up of data for ASD group versus non-clinical comparison 
group.  
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Sample information sheets 
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Sample consent forms 
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Invitation letter sent to ASD research database participants 
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Invitation letter sent to individuals on the IAPT database 
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